{
 "version": "2.2",
 "instance": {
  "ea0306842-20f_radiopharm.htm": {
   "nsprefix": "radx",
   "nsuri": "http://radx.com/20260630",
   "dts": {
    "inline": {
     "local": [
      "ea0306842-20f_radiopharm.htm"
     ]
    },
    "schema": {
     "local": [
      "radx-20260630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "radx-20260630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "radx-20260630_def.xml"
     ],
     "remote": [
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml"
     ]
    },
    "labelLink": {
     "local": [
      "radx-20260630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "radx-20260630_pre.xml"
     ]
    }
   },
   "keyStandard": 263,
   "keyCustom": 126,
   "axisStandard": 31,
   "axisCustom": 2,
   "memberStandard": 18,
   "memberCustom": 220,
   "hidden": {
    "total": 447,
    "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 302,
    "http://radx.com/20260630": 142,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 632,
   "entityCount": 1,
   "segmentCount": 260,
   "elementCount": 978,
   "unitCount": 8,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 1435,
    "http://xbrl.sec.gov/dei/2025": 47,
    "http://xbrl.sec.gov/cyd/2025": 6,
    "http://xbrl.sec.gov/ecd/2025": 1
   },
   "report": {
    "R1": {
     "role": "http://radx.com/20260630/role/Cover",
     "longName": "995300 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://radx.com/20260630/role/AuditInformation",
     "longName": "995301 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
     "longName": "995302 - Statement - Consolidated Statements of Profit or Loss and Other Comprehensive Income",
     "shortName": "Consolidated Statements of Profit or Loss and Other Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:GrossProfit",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
     "longName": "995303 - Statement - Consolidated Statements of Financial Position",
     "shortName": "Consolidated Statements of Financial Position",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
     "longName": "995304 - Statement - Consolidated Statement of Changes in Equity",
     "shortName": "Consolidated Statement of Changes in Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "cref_745832050",
      "name": "ifrs-full:Equity",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_745832050",
      "name": "ifrs-full:Equity",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows",
     "longName": "995305 - Statement - Consolidated Statement of Cash Flows",
     "shortName": "Consolidated Statement of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ReceiptsFromSalesOfGoodsAndRenderingOfServices",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ReceiptsFromSalesOfGoodsAndRenderingOfServices",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://radx.com/20260630/role/SegmentInformation",
     "longName": "995306 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://radx.com/20260630/role/RevenuefromContractwithCustomers",
     "longName": "995307 - Disclosure - Revenue from Contract with Customers",
     "shortName": "Revenue from Contract with Customers",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://radx.com/20260630/role/OtherIncomeandExpenseItems",
     "longName": "995308 - Disclosure - Other Income and Expense Items",
     "shortName": "Other Income and Expense Items",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://radx.com/20260630/role/IncomeTaxExpense",
     "longName": "995309 - Disclosure - Income Tax Expense",
     "shortName": "Income Tax Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilities",
     "longName": "995310 - Disclosure - Financial Assets and Financial Liabilities",
     "shortName": "Financial Assets and Financial Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://radx.com/20260630/role/NonfinancialAssetsandLiabilities",
     "longName": "995311 - Disclosure - Non-financial Assets and Liabilities",
     "shortName": "Non-financial Assets and Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://radx.com/20260630/role/Equity",
     "longName": "995312 - Disclosure - Equity",
     "shortName": "Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://radx.com/20260630/role/CashFlowInformation",
     "longName": "995313 - Disclosure - Cash Flow Information",
     "shortName": "Cash Flow Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfCashFlowInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfCashFlowInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://radx.com/20260630/role/MaterialEstimatesandJudgements",
     "longName": "995314 - Disclosure - Material Estimates and Judgements",
     "shortName": "Material Estimates and Judgements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://radx.com/20260630/role/FinancialRiskManagement",
     "longName": "995315 - Disclosure - Financial Risk Management",
     "shortName": "Financial Risk Management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://radx.com/20260630/role/CapitalManagement",
     "longName": "995316 - Disclosure - Capital Management",
     "shortName": "Capital Management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfCapitalManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfCapitalManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://radx.com/20260630/role/InterestsinOtherEntities",
     "longName": "995317 - Disclosure - Interests in Other Entities",
     "shortName": "Interests in Other Entities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://radx.com/20260630/role/ContingentConsideration",
     "longName": "995318 - Disclosure - Contingent Consideration",
     "shortName": "Contingent Consideration",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://radx.com/20260630/role/Commitments",
     "longName": "995319 - Disclosure - Commitments",
     "shortName": "Commitments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://radx.com/20260630/role/RelatedPartyTransactions",
     "longName": "995320 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://radx.com/20260630/role/ShareBasedPayments",
     "longName": "995321 - Disclosure - Share-Based Payments",
     "shortName": "Share-Based Payments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://radx.com/20260630/role/RemunerationofAuditors",
     "longName": "995322 - Disclosure - Remuneration of Auditors",
     "shortName": "Remuneration of Auditors",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://radx.com/20260630/role/LossPerShare",
     "longName": "995323 - Disclosure - Loss Per Share",
     "shortName": "Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://radx.com/20260630/role/ParentEntityFinancialInformation",
     "longName": "995324 - Disclosure - Parent Entity Financial Information",
     "shortName": "Parent Entity Financial Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://radx.com/20260630/role/SummaryofMaterialAccountingPolicies",
     "longName": "995325 - Disclosure - Summary of Material Accounting Policies",
     "shortName": "Summary of Material Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://radx.com/20260630/role/EventsOccurringAftertheReportingYear",
     "longName": "995326 - Disclosure - Events Occurring After the Reporting Year",
     "shortName": "Events Occurring After the Reporting Year",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies",
     "longName": "996328 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "30",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://radx.com/20260630/role/RevenuefromContractwithCustomersTables",
     "longName": "996329 - Disclosure - Revenue from Contract with Customers (Tables)",
     "shortName": "Revenue from Contract with Customers (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://radx.com/20260630/role/OtherIncomeandExpenseItemsTables",
     "longName": "996330 - Disclosure - Other Income and Expense Items (Tables)",
     "shortName": "Other Income and Expense Items (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfOtherIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfOtherIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://radx.com/20260630/role/IncomeTaxExpenseTables",
     "longName": "996331 - Disclosure - Income Tax Expense (Tables)",
     "shortName": "Income Tax Expense (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfNumericalReconciliationOfIncomeTaxExpenseToPrimaFacieTaxPayableExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfNumericalReconciliationOfIncomeTaxExpenseToPrimaFacieTaxPayableExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesTables",
     "longName": "996332 - Disclosure - Financial Assets and Financial Liabilities (Tables)",
     "shortName": "Financial Assets and Financial Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesTables",
     "longName": "996333 - Disclosure - Non-financial Assets and Liabilities (Tables)",
     "shortName": "Non-financial Assets and Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://radx.com/20260630/role/EquityTables",
     "longName": "996334 - Disclosure - Equity (Tables)",
     "shortName": "Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://radx.com/20260630/role/CashFlowInformationTables",
     "longName": "996335 - Disclosure - Cash Flow Information (Tables)",
     "shortName": "Cash Flow Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "radx:DisclosureOfCashFlowInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "radx:DisclosureOfCashFlowInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://radx.com/20260630/role/FinancialRiskManagementTables",
     "longName": "996336 - Disclosure - Financial Risk Management (Tables)",
     "shortName": "Financial Risk Management (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://radx.com/20260630/role/InterestsinOtherEntitiesTables",
     "longName": "996337 - Disclosure - Interests in Other Entities (Tables)",
     "shortName": "Interests in Other Entities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://radx.com/20260630/role/ContingentConsiderationTables",
     "longName": "996338 - Disclosure - Contingent Consideration (Tables)",
     "shortName": "Contingent Consideration (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfDevelopmentMilestonePaymentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:DisclosureOfDevelopmentMilestonePaymentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://radx.com/20260630/role/RelatedPartyTransactionsTables",
     "longName": "996339 - Disclosure - Related Party Transactions (Tables)",
     "shortName": "Related Party Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://radx.com/20260630/role/ShareBasedPaymentsTables",
     "longName": "996340 - Disclosure - Share-Based Payments (Tables)",
     "shortName": "Share-Based Payments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://radx.com/20260630/role/RemunerationofAuditorsTables",
     "longName": "996341 - Disclosure - Remuneration of Auditors (Tables)",
     "shortName": "Remuneration of Auditors (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:ScheduleOfPayableForServicesByTheAuditorTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:ScheduleOfPayableForServicesByTheAuditorTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://radx.com/20260630/role/LossPerShareTables",
     "longName": "996342 - Disclosure - Loss Per Share (Tables)",
     "shortName": "Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://radx.com/20260630/role/ParentEntityFinancialInformationTables",
     "longName": "996343 - Disclosure - Parent Entity Financial Information (Tables)",
     "shortName": "Parent Entity Financial Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://radx.com/20260630/role/SegmentInformationDetails",
     "longName": "996344 - Disclosure - Segment Information (Details)",
     "shortName": "Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:NumberOfReportablesSegments",
      "unitRef": "uref_1642879776",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:NumberOfReportablesSegments",
      "unitRef": "uref_1642879776",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://radx.com/20260630/role/RevenuefromContractwithCustomersDetails",
     "longName": "996345 - Disclosure - Revenue from Contract with Customers (Details)",
     "shortName": "Revenue from Contract with Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofRevenuefromContractwithCustomersDetails",
     "longName": "996346 - Disclosure - Revenue from Contract with Customers - Schedule of Revenue from Contract with Customers (Details)",
     "shortName": "Revenue from Contract with Customers - Schedule of Revenue from Contract with Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R49": {
     "role": "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetails",
     "longName": "996347 - Disclosure - Revenue from Contract with Customers - Schedule of Information on Geographical Regions (Details)",
     "shortName": "Revenue from Contract with Customers - Schedule of Information on Geographical Regions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_469194671",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "uref_1001896052",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonMajorCustomersDetails",
     "longName": "996348 - Disclosure - Revenue from Contract with Customers - Schedule of Information on Major Customers (Details)",
     "shortName": "Revenue from Contract with Customers - Schedule of Information on Major Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1680492102",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "uref_1001896052",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfSegmentsMajorCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails",
     "longName": "996349 - Disclosure - Other Income and Expense Items (Details)",
     "shortName": "Other Income and Expense Items (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:OtherIncome",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_2065535967",
      "name": "ifrs-full:OtherIncome",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofOtherincomeDetails",
     "longName": "996350 - Disclosure - Other Income and Expense Items - Schedule of Other income (Details)",
     "shortName": "Other Income and Expense Items - Schedule of Other income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:InterestIncome",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfOtherIncomeTableTextBlock",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:InterestIncome",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfOtherIncomeTableTextBlock",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofOtherLossesDetails",
     "longName": "996351 - Disclosure - Other Income and Expense Items - Schedule of Other Losses (Details)",
     "shortName": "Other Income and Expense Items - Schedule of Other Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "cref_198500851",
      "name": "ifrs-full:AdjustmentsForFairValueGainsLosses",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfOtherLossesTableTextBlock",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_198500851",
      "name": "ifrs-full:AdjustmentsForFairValueGainsLosses",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfOtherLossesTableTextBlock",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails",
     "longName": "996352 - Disclosure - Other Income and Expense Items - Schedule of Breakdown of Expenses by Nature (Details)",
     "shortName": "Other Income and Expense Items - Schedule of Breakdown of Expenses by Nature (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:GeneralAndAdministrativeExpense",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_160260067",
      "name": "ifrs-full:GeneralAndAdministrativeExpense",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://radx.com/20260630/role/IncomeTaxExpenseDetails",
     "longName": "996353 - Disclosure - Income Tax Expense (Details)",
     "shortName": "Income Tax Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:PecentageOfFederalTaxRate",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:PecentageOfFederalTaxRate",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails",
     "longName": "996354 - Disclosure - Income Tax Expense - Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable (Details)",
     "shortName": "Income Tax Expense - Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1937830845",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetails",
     "longName": "996355 - Disclosure - Income Tax Expense - Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable (Parentheticals) (Details)",
     "shortName": "Income Tax Expense - Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable (Parentheticals) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "cref_1937830845",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1937830845",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesDetails",
     "longName": "996356 - Disclosure - Income Tax Expense - Schedule of Tax Losses (Details)",
     "shortName": "Income Tax Expense - Schedule of Tax Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "cref_1699112522",
      "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1699112522",
      "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetails",
     "longName": "996357 - Disclosure - Income Tax Expense - Schedule of Tax Losses (Parentheticals) (Details)",
     "shortName": "Income Tax Expense - Schedule of Tax Losses (Parentheticals) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "cref_1699112522",
      "name": "radx:PotentialTaxBenefitRate",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1699112522",
      "name": "radx:PotentialTaxBenefitRate",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofIncomeTaxExpenseDetails",
     "longName": "996358 - Disclosure - Income Tax Expense - Schedule of Income Tax Expense (Details)",
     "shortName": "Income Tax Expense - Schedule of Income Tax Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesDetails",
     "longName": "996359 - Disclosure - Financial Assets and Financial Liabilities (Details)",
     "shortName": "Financial Assets and Financial Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "radx:AccruedReceivablesCurrent",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1305557533",
      "name": "radx:AccruedReceivablesCurrent",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofCashandCashEquivalentsDetails",
     "longName": "996360 - Disclosure - Financial Assets and Financial Liabilities - Schedule of Cash and Cash Equivalents (Details)",
     "shortName": "Financial Assets and Financial Liabilities - Schedule of Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:Cash",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:Cash",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofConsolidatedStatementofCashFlowsDetails",
     "longName": "996361 - Disclosure - Financial Assets and Financial Liabilities - Schedule of Consolidated Statement of Cash Flows (Details)",
     "shortName": "Financial Assets and Financial Liabilities - Schedule of Consolidated Statement of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R64": {
     "role": "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails",
     "longName": "996362 - Disclosure - Financial Assets and Financial Liabilities - Schedule of Trade and Other Receivables (Details)",
     "shortName": "Financial Assets and Financial Liabilities - Schedule of Trade and Other Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:TradeAndOtherCurrentReceivables",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_404292157",
      "name": "ifrs-full:TradeAndOtherCurrentReceivables",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails",
     "longName": "996363 - Disclosure - Financial Assets and Financial Liabilities - Schedule of Trade and Other Payables (Details)",
     "shortName": "Financial Assets and Financial Liabilities - Schedule of Trade and Other Payables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:TradeAndOtherCurrentPayables",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_404292157",
      "name": "ifrs-full:TradeAndOtherCurrentPayables",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails",
     "longName": "996364 - Disclosure - Financial Assets and Financial Liabilities - Schedule of Other Financial Liabilities (Details)",
     "shortName": "Financial Assets and Financial Liabilities - Schedule of Other Financial Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:OtherCurrentFinancialLiabilities",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_158447489",
      "name": "ifrs-full:OtherCurrentFinancialLiabilities",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
     "longName": "996365 - Disclosure - Financial Assets and Financial Liabilities - Schedule of Financial Liabilities with Significant Estimation Uncertainty (Details)",
     "shortName": "Financial Assets and Financial Liabilities - Schedule of Financial Liabilities with Significant Estimation Uncertainty (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfFairValueMeasurementExplanatory",
       "ifrs-full:DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails",
     "longName": "996366 - Disclosure - Non-financial Assets and Liabilities (Details)",
     "shortName": "Non-financial Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:CurrentProvisionsForEmployeeBenefits",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:FullAmountOfAccruedLeaveOrRequirePayment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails",
     "longName": "996367 - Disclosure - Non-financial Assets and Liabilities - Schedule of Intangible Assets (Details)",
     "shortName": "Non-financial Assets and Liabilities - Schedule of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "cref_1963669158",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_404292157",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofEmployeeBenefitObligationsDetails",
     "longName": "996368 - Disclosure - Non-financial Assets and Liabilities - Schedule of Employee Benefit Obligations (Details)",
     "shortName": "Non-financial Assets and Liabilities - Schedule of Employee Benefit Obligations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:CurrentProvisionsForEmployeeBenefits",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:ProvisionsForEmployeeBenefits",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "ifrs-full:DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://radx.com/20260630/role/EquityScheduleofShareCapitalDetails",
     "longName": "996369 - Disclosure - Equity - Schedule of Share Capital (Details)",
     "shortName": "Equity - Schedule of Share Capital (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:NumberOfSharesIssuedAndFullyPaid",
      "unitRef": "uref_1634518116",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:NumberOfSharesIssuedAndFullyPaid",
      "unitRef": "uref_1634518116",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
     "longName": "996370 - Disclosure - Equity - Schedule of Movements in Ordinary Shares (Details)",
     "shortName": "Equity - Schedule of Movements in Ordinary Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "cref_1963669158",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "uref_1634518116",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1305557533",
      "name": "radx:TransactionCostsArisingOnShareIssuesValue",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails",
     "longName": "996371 - Disclosure - Equity - Schedule of Movements in Ordinary Shares (Parentheticals) (Details)",
     "shortName": "Equity - Schedule of Movements in Ordinary Shares (Parentheticals) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "cref_1115980466",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "uref_1453202449",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1115980466",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "uref_1453202449",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails",
     "longName": "996372 - Disclosure - Equity - Schedule of Statement of Financial Position Line Item \u2018Other Reserves\u2019 and the Movements in These Reserves During the Year and Period (Details)",
     "shortName": "Equity - Schedule of Statement of Financial Position Line Item \u2018Other Reserves\u2019 and the Movements in These Reserves During the Year and Period (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "cref_1963669158",
      "name": "ifrs-full:OtherReserves",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1052646885",
      "name": "radx:IncreaseDecreaseThroughIssueOfSharesAsPartOfPlacement",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails",
     "longName": "996373 - Disclosure - Equity - Schedule of Movements in Options (Details)",
     "shortName": "Equity - Schedule of Movements in Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "cref_327595348",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfMovementsInOptionsExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_435790906",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfMovementsInOptionsExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://radx.com/20260630/role/EquityScheduleofOtherEquityDetails",
     "longName": "996374 - Disclosure - Equity - Schedule of Other Equity (Details)",
     "shortName": "Equity - Schedule of Other Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "cref_1963669158",
      "name": "ifrs-full:OtherEquityInterest",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R77": {
     "role": "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails",
     "longName": "996375 - Disclosure - Cash Flow Information - Schedule of Reconciliation of Profit After Income Tax to Net Cash Inflow From Operating Activities (Details)",
     "shortName": "Cash Flow Information - Schedule of Reconciliation of Profit After Income Tax to Net Cash Inflow From Operating Activities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory",
       "radx:DisclosureOfCashFlowInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails",
     "longName": "996376 - Disclosure - Material Estimates and Judgements (Details)",
     "shortName": "Material Estimates and Judgements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DateOfGrantOfSharebasedPaymentArrangement",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:MileStonePayments",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://radx.com/20260630/role/FinancialRiskManagementDetails",
     "longName": "996377 - Disclosure - Financial Risk Management (Details)",
     "shortName": "Financial Risk Management (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:ExposedInterestRateRisk",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:ExposedInterestRateRisk",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails",
     "longName": "996378 - Disclosure - Financial Risk Management - Schedule of Exposure to Foreign Currency Risk (Details)",
     "shortName": "Financial Risk Management - Schedule of Exposure to Foreign Currency Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1502965910",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails",
     "longName": "996379 - Disclosure - Financial Risk Management - Schedule of Impact of Foreign Currency Risk (Details)",
     "shortName": "Financial Risk Management - Schedule of Impact of Foreign Currency Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "cref_334748240",
      "name": "radx:ImpactOnPosttaxLoss",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfImpactOfForeignCurrencyRiskTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_334748240",
      "name": "radx:ImpactOnPosttaxLoss",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfImpactOfForeignCurrencyRiskTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetails",
     "longName": "996380 - Disclosure - Financial Risk Management - Schedule of Impact of Foreign Currency Risk (Parentheticals) (Details)",
     "shortName": "Financial Risk Management - Schedule of Impact of Foreign Currency Risk (Parentheticals) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "cref_334748240",
      "name": "radx:ExchangeRate",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfImpactOfForeignCurrencyRiskTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_334748240",
      "name": "radx:ExchangeRate",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfImpactOfForeignCurrencyRiskTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails",
     "longName": "996381 - Disclosure - Financial Risk Management - Schedule of Exposure to Interest Rate Risk (Details)",
     "shortName": "Financial Risk Management - Schedule of Exposure to Interest Rate Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_517081436",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfExposureToInterestRateRiskTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofInterestRateRiskDetails",
     "longName": "996382 - Disclosure - Financial Risk Management - Schedule of Impact of Interest Rate Risk (Details)",
     "shortName": "Financial Risk Management - Schedule of Impact of Interest Rate Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "cref_517081436",
      "name": "radx:ImpactOnPosttaxLoss",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfImpactOfInterestRateRiskTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_517081436",
      "name": "radx:ImpactOnPosttaxLoss",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfImpactOfInterestRateRiskTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails",
     "longName": "996383 - Disclosure - Financial Risk Management - Schedule of Maturities of Financial Liabilities (Details)",
     "shortName": "Financial Risk Management - Schedule of Maturities of Financial Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfMaturitiesOfFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1963669158",
      "name": "radx:ContractualMaturitiesOfFinancialLiabilities",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfMaturitiesOfFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://radx.com/20260630/role/CapitalManagementDetails",
     "longName": "996384 - Disclosure - Capital Management (Details)",
     "shortName": "Capital Management (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R87": {
     "role": "http://radx.com/20260630/role/InterestsinOtherEntitiesDetails",
     "longName": "996385 - Disclosure - Interests in Other Entities (Details)",
     "shortName": "Interests in Other Entities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "cref_1098178729",
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1098178729",
      "name": "ifrs-full:ProportionOfOwnershipInterestInSubsidiary",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails",
     "longName": "996386 - Disclosure - Interests in Other Entities - Schedule of Group\u2019s Subsidiaries (Details)",
     "shortName": "Interests in Other Entities - Schedule of Group\u2019s Subsidiaries (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "cref_126621",
      "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_126621",
      "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
       "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails",
     "longName": "996387 - Disclosure - Interests in Other Entities - Schedule of Summarized Balance Sheet (Details)",
     "shortName": "Interests in Other Entities - Schedule of Summarized Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1773416733",
      "name": "ifrs-full:NoncurrentAssets",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfSummarizedBalanceSheetTextBlock",
       "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetails",
     "longName": "996388 - Disclosure - Interests in Other Entities - Schedule of Summarized Statement of Comprehensive Loss (Details)",
     "shortName": "Interests in Other Entities - Schedule of Summarized Statement of Comprehensive Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1302339560",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfSummarizedStatementOfComprehensiveLossTextBlock",
       "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://radx.com/20260630/role/ContingentConsiderationDetails",
     "longName": "996389 - Disclosure - Contingent Consideration (Details)",
     "shortName": "Contingent Consideration (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "cref_1350153857",
      "name": "ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1350153857",
      "name": "ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails",
     "longName": "996390 - Disclosure - Contingent Consideration - Schedule of Development Milestone Payments (Details)",
     "shortName": "Contingent Consideration - Schedule of Development Milestone Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "cref_2125799627",
      "name": "radx:Milestonepayment",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfDevelopmentMilestonePaymentsExplanatory",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_2125799627",
      "name": "radx:Milestonepayment",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfDevelopmentMilestonePaymentsExplanatory",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsDetails",
     "longName": "996391 - Disclosure - Contingent Consideration - Schedule of Commercialization Payments (Details)",
     "shortName": "Contingent Consideration - Schedule of Commercialization Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "cref_1703580672",
      "name": "radx:CommercializationPayment",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1703580672",
      "name": "radx:CommercializationPayment",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetails",
     "longName": "996392 - Disclosure - Contingent Consideration - Schedule of Commercialization Payments (Parentheticals) (Details)",
     "shortName": "Contingent Consideration - Schedule of Commercialization Payments (Parentheticals) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "cref_1047837936",
      "name": "radx:NetSalesOfAllLicensedProductsExceedingValue",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1047837936",
      "name": "radx:NetSalesOfAllLicensedProductsExceedingValue",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
       "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://radx.com/20260630/role/CommitmentsDetails",
     "longName": "996393 - Disclosure - Commitments (Details)",
     "shortName": "Commitments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:LicenceFeeIncome",
      "unitRef": "uref_1001896052",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:LicenceFeeIncome",
      "unitRef": "uref_1001896052",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://radx.com/20260630/role/RelatedPartyTransactionsDetails",
     "longName": "996394 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "cref_198500851",
      "name": "radx:AmountPayableInCash",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_198500851",
      "name": "radx:AmountPayableInCash",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails",
     "longName": "996395 - Disclosure - Related Party Transactions - Schedule of Key Management Personnel Compensation (Details)",
     "shortName": "Related Party Transactions - Schedule of Key Management Personnel Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonnelDetails",
     "longName": "996396 - Disclosure - Related Party Transactions - Schedule of Transactions with Key Management Personnel (Details)",
     "shortName": "Related Party Transactions - Schedule of Transactions with Key Management Personnel (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:TransactionsOccurredWithKeyManagementPersonnel",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:TransactionsOccurredWithKeyManagementPersonnel",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails",
     "longName": "996397 - Disclosure - Share-Based Payments - Schedule of Employee Option Plan (Details)",
     "shortName": "Share-Based Payments - Schedule of Employee Option Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "cref_530068751",
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
      "unitRef": "uref_1453202449",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_875901779",
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
      "unitRef": "uref_1453202449",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails",
     "longName": "996398 - Disclosure - Share-Based Payments - Schedule of Share Options Outstanding (Details)",
     "shortName": "Share-Based Payments - Schedule of Share Options Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "cref_1304073823",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1304073823",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R101": {
     "role": "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails",
     "longName": "996399 - Disclosure - Share-Based Payments - Schedule of Model Inputs for Options Granted (Details)",
     "shortName": "Share-Based Payments - Schedule of Model Inputs for Options Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DescriptionOfOptionLifeShareOptionsGranted",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:DescriptionOfOptionLifeShareOptionsGranted",
      "unitRef": "uref_880450695",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofExpensesArisingfromShareBasedPaymentTransactionsDetails",
     "longName": "996400 - Disclosure - Share-Based Payments - Schedule of Expenses Arising from Share-Based Payment Transactions (Details)",
     "shortName": "Share-Based Payments - Schedule of Expenses Arising from Share-Based Payment Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails",
     "longName": "996401 - Disclosure - Remuneration of Auditors - Schedule of Payable for Services by the Auditor (Details)",
     "shortName": "Remuneration of Auditors - Schedule of Payable for Services by the Auditor (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "cref_414897961",
      "name": "ifrs-full:AuditorsRemuneration",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfPayableForServicesByTheAuditorTextBlock",
       "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_414897961",
      "name": "ifrs-full:AuditorsRemuneration",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:ScheduleOfPayableForServicesByTheAuditorTextBlock",
       "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://radx.com/20260630/role/LossPerShareScheduleofReconciliationsofLossUsedinCalculatingLossPerShareDetails",
     "longName": "996402 - Disclosure - Loss Per Share - Schedule of Reconciliations of Loss Used in Calculating Loss Per Share (Details)",
     "shortName": "Loss Per Share - Schedule of Reconciliations of Loss Used in Calculating Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:BasicEarningsLossPerShareFromContinuingOperations",
      "unitRef": "uref_1453202449",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:BasicEarningsLossPerShareFromContinuingOperations",
      "unitRef": "uref_1453202449",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://radx.com/20260630/role/LossPerShareScheduleofWeightedAverageNumberofSharesUsedastheDenominatorDetails",
     "longName": "996403 - Disclosure - Loss Per Share - Schedule of Weighted Average Number of Shares Used as the Denominator (Details)",
     "shortName": "Loss Per Share - Schedule of Weighted Average Number of Shares Used as the Denominator (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:WeightedAverageShares",
      "unitRef": "uref_1634518116",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfWeightedAverageNumberOfSharesUsedAsTheDenominatorExplanatoryTextBlock",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:WeightedAverageShares",
      "unitRef": "uref_1634518116",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "radx:DisclosureOfWeightedAverageNumberOfSharesUsedAsTheDenominatorExplanatoryTextBlock",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://radx.com/20260630/role/ParentEntityFinancialInformationDetails",
     "longName": "996404 - Disclosure - Parent Entity Financial Information (Details)",
     "shortName": "Parent Entity Financial Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R107": {
     "role": "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails",
     "longName": "996405 - Disclosure - Parent Entity Financial Information - Schedule of Financial Statements (Details)",
     "shortName": "Parent Entity Financial Information - Schedule of Financial Statements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "cref_1305557533",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_442824516",
      "name": "ifrs-full:IssuedCapitalOrdinaryShares",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "ifrs-full:DisclosureOfIssuedCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R108": {
     "role": "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails",
     "longName": "996406 - Disclosure - Summary of Material Accounting Policies (Details)",
     "shortName": "Summary of Material Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "cref_1085778750",
      "name": "ifrs-full:ComprehensiveIncome",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1085778750",
      "name": "radx:MaximumOverdueDays",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "unique": true
     }
    },
    "R109": {
     "role": "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails",
     "longName": "996407 - Disclosure - Events Occurring After the Reporting Year (Details)",
     "shortName": "Events Occurring After the Reporting Year (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "cref_138071911",
      "name": "radx:AmountUsed",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_138071911",
      "name": "radx:AmountUsed",
      "unitRef": "uref_138071911",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0306842-20f_radiopharm.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "country_AU": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "AU",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Australia [Member]",
        "label": "AUSTRALIA"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AVb6IntegrinIntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AVb6IntegrinIntellectualPropertyMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AVb6 Integrin intellectual property [member]",
        "label": "AVb6 Integrin Intellectual Property Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AVb6IntegrinMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AVb6IntegrinMember",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AVb6 Integrin [Member]",
        "label": "AVb6 Integrin Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AVb6IntegrinTRIMTMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AVb6IntegrinTRIMTMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AVb6 Integrin (TRIMT) [Member]",
        "label": "AVb6 Integrin TRIMTMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AccountingAndAuditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AccountingAndAuditMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting and audit [Member]",
        "label": "Accounting And Audit Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AccruedExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AccruedExpensesMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses [Member]",
        "label": "Accrued Expenses Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AccruedReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AccruedReceivablesCurrent",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued receivables",
        "label": "Accrued Receivables Current",
        "documentation": "The amount of accrued receivables."
       }
      }
     },
     "auth_ref": []
    },
    "radx_AccruedReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AccruedReceivablesMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued receivables [Member]",
        "label": "Accrued Receivables Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccumulatedOtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "Accumulated other comprehensive income"
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "radx_AchievementOfAMilestoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AchievementOfAMilestoneMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Achievement of a milestone [Member]",
        "label": "Achievement Of AMilestone Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfDiscountRates",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Actuarial assumption of discount rates"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://radx.com/20260630/role/LossPerShareScheduleofWeightedAverageNumberofSharesUsedastheDenominatorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of ordinary shares used as the denominator in calculating diluted loss per share",
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "radx_AdjustmentsForAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AdjustmentsForAbstract",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments for",
        "label": "Adjustments For Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInFinancialAssetsHeldForTrading": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInFinancialAssetsHeldForTrading",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration",
        "label": "Adjustments for decrease (increase) in financial assets held for trading"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in financial assets held for trading to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Financial assets; Financial assets at fair value through profit or loss, classified as held for trading; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInOtherCurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in other current assets",
        "label": "Adjustments for decrease (increase) in other current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other current assets; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in trade receivables",
        "label": "Adjustments for decrease (increase) in trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Adjustments for depreciation and amortisation expense"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ifrs-full_AdjustmentsForFairValueGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForFairValueGainsLosses",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofOtherLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value adjustment on financing agreements",
        "label": "Adjustments for fair value losses (gains)"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ifrs-full_AdjustmentsForFinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForFinanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance costs",
        "label": "Adjustments for finance costs"
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "ifrs-full_AdjustmentsForFinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForFinanceIncome",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance income",
        "label": "Adjustments for finance income"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment",
        "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in trade payables",
        "label": "Adjustments for increase (decrease) in trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal of intellectual property",
        "label": "Adjustments for losses (gains) on disposal of non-current assets"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_AdjustmentsForProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForProvisions",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leave provision",
        "label": "Adjustments for provisions"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Profit After Income Tax to Net Cash Inflow From Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails",
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments",
        "negatedLabel": "Share-based payments expenses",
        "label": "Adjustments for share-based payments"
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net foreign currency (gains)/losses",
        "label": "Adjustments for unrealised foreign exchange losses (gains)"
       }
      }
     },
     "auth_ref": [
      "r294",
      "r436"
     ]
    },
    "radx_AdvancePaymentLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AdvancePaymentLiabilityMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advance Payment Liability [Member]",
        "label": "Advance Payment Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AdvancedPaymentLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AdvancedPaymentLiabilityMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advanced Payment Liability [Member]",
        "label": "Advanced Payment Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AggregateNetSalesWorldwideExceedingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AggregateNetSalesWorldwideExceedingMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Net Sales worldwide exceeding [member]",
        "label": "Aggregate Net Sales Worldwide Exceeding Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AggregateNetSalesWorldwideExceedingOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AggregateNetSalesWorldwideExceedingOneMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Net Sales worldwide exceeding [member]",
        "label": "Aggregate Net Sales Worldwide Exceeding One Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r342",
      "r353",
      "r363",
      "r396"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r345",
      "r356",
      "r366",
      "r399"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2025",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r367",
      "r391",
      "r400",
      "r404",
      "r412"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "radx_AmericanDepositaryShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AmericanDepositaryShareMember",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ADS [Member]",
        "label": "American Depositary Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulation amortization and impairment",
        "label": "Amortisation, intangible assets other than goodwill"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r205"
     ]
    },
    "radx_AmortizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AmortizationMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization [Member]",
        "label": "Amortization Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AmountOfInstitutionalLaunched": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AmountOfInstitutionalLaunched",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Institutional Launched",
        "documentation": "Amount of institutional launched."
       }
      }
     },
     "auth_ref": []
    },
    "radx_AmountOfInstitutionalOffer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AmountOfInstitutionalOffer",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Institutional Offer",
        "documentation": "Amount of institutional offer."
       }
      }
     },
     "auth_ref": []
    },
    "radx_AmountPayableInCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AmountPayableInCash",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable in cash",
        "label": "Amount Payable In Cash",
        "documentation": "Amount payable in cash."
       }
      }
     },
     "auth_ref": []
    },
    "radx_AmountUsed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AmountUsed",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Institutional offer",
        "label": "Amount Used",
        "documentation": "Amount of institutional offer."
       }
      }
     },
     "auth_ref": []
    },
    "radx_AmountsDueToEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AmountsDueToEmployeesMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts due to employees [Member]",
        "label": "Amounts Due To Employees Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmountsPayableRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans",
        "label": "Amounts payable, related party transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r25",
      "r197"
     ]
    },
    "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AnalysisOfIncomeAndExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expense Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AndersonForAnyOtherLicencedProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AndersonForAnyOtherLicencedProductMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anderson for any other licenced product [member]",
        "label": "Anderson For Any Other Licenced Product Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AndersonForLicencedProductsThatTargetBSevenHThreeAndorAreCoveredByBSevenHThreePatentRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AndersonForLicencedProductsThatTargetBSevenHThreeAndorAreCoveredByBSevenHThreePatentRightsMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Anderson for Licenced products that target B7-H3 and/or are covered by B7-H3 patent rights [member]",
        "label": "Anderson For Licenced Products That Target BSeven HThree Andor Are Covered By BSeven HThree Patent Rights Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AnyMarketingApprovalInJapanChinaHongKongOrTheUnitedStatesOf68GaTRIVEHEXINForDiagnosticApplicationDiagnosticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AnyMarketingApprovalInJapanChinaHongKongOrTheUnitedStatesOf68GaTRIVEHEXINForDiagnosticApplicationDiagnosticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Any Marketing Approval in Japan, China, Hong Kong or the United States of (68Ga-TRIVEHEXIN) for diagnostic application (Diagnostic) [member]",
        "label": "Any Marketing Approval In Japan China Hong Kong Or The United States Of68 Ga TRIVEHEXINFor Diagnostic Application Diagnostic Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AnyMarketingApprovalInTheTerritoryOtherThanInAustraliaTherapeuticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AnyMarketingApprovalInTheTerritoryOtherThanInAustraliaTherapeuticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Any Marketing Approval in the Territory other than in Australia (Therapeutic) [member]",
        "label": "Any Marketing Approval In The Territory Other Than In Australia Therapeutic Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax at the rate",
        "label": "Applicable tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r186"
     ]
    },
    "radx_ApprovalAtFirstOfFDAEMAPMDAForDiagnosticTrialsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ApprovalAtFirstOfFDAEMAPMDAForDiagnosticTrialsMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Approval at first of FDA, EMA, PMDA for Diagnostic trials [member]",
        "label": "Approval At First Of FDAEMAPMDAFor Diagnostic Trials Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_NetAssetsLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r150",
      "r153",
      "r231",
      "r232",
      "r262"
     ]
    },
    "ifrs-full_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Statement of financial position",
        "label": "Assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [axis]"
       }
      }
     },
     "auth_ref": [
      "r444",
      "r446"
     ]
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionDomain",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [domain]"
       }
      }
     },
     "auth_ref": [
      "r444",
      "r446"
     ]
    },
    "radx_AuditAndOtherAssuranceServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AuditAndOtherAssuranceServicesMember",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Audit and other assurance services [Member]",
        "label": "Audit And Other Assurance Services Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AuditAndReviewOfFinancialStatementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AuditAndReviewOfFinancialStatementsMember",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Audit and review of financial statements\t[Member]",
        "label": "Audit And Review Of Financial Statements Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AuditOfNASDAQRegistrationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AuditOfNASDAQRegistrationMember",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Audit of NASDAQ registration [Member]",
        "label": "Audit Of NASDAQRegistration Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://radx.com/20260630/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r349"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://radx.com/20260630/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r349"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://radx.com/20260630/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r349"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "ifrs-full_AuditorsRemuneration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AuditorsRemuneration",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total auditors\u2019 remuneration",
        "label": "Auditor's remuneration"
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "ifrs-full_AuditorsRemunerationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AuditorsRemunerationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Remuneration of Auditors [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AustralianTaxExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AustralianTaxExpenseMember",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Australian tax expense [Member]",
        "label": "Australian Tax Expense Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_AverageCashInterestRateRiskPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AverageCashInterestRateRiskPercentage",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average cash interest rate risk",
        "label": "Average Cash Interest Rate Risk Percentage",
        "documentation": "Average cash interest rate risk."
       }
      }
     },
     "auth_ref": []
    },
    "radx_AverageChangeToCashInterestRateRisk": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "AverageChangeToCashInterestRateRisk",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average change to cash interest rate risk",
        "label": "Average Change To Cash Interest Rate Risk",
        "documentation": "Average change to cash interest rate risk."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "radx_BalancesAsAboveAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "BalancesAsAboveAbstract",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofConsolidatedStatementofCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balances as above",
        "label": "Balances As Above Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic loss per share (in Dollars per share)",
        "label": "Basic earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37"
     ]
    },
    "ifrs-full_BasicEarningsLossPerShareFromContinuingOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShareFromContinuingOperations",
     "presentation": [
      "http://radx.com/20260630/role/LossPerShareScheduleofReconciliationsofLossUsedinCalculatingLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic loss per share from continuing operations",
        "label": "Basic earnings (loss) per share from continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations, unless line item indicates otherwise [member]]"
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37"
     ]
    },
    "ifrs-full_BasicEarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BasicEarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliations of Loss Used in Calculating Loss Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Between1And2YearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Between1And2YearsMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Between 1 and 2 years [Member]",
        "label": "Between1 And2 Years Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Between2And5YearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Between2And5YearsMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Between 2 and 5 years [Member]",
        "label": "Between2 And5 Years Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Bottom of range [member]",
        "verboseLabel": "Bottom of Range [Member]",
        "terseLabel": "Bottom of range [Member]",
        "label": "Bottom of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r97",
      "r107",
      "r122",
      "r175",
      "r297",
      "r298",
      "r441"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r331",
      "r349"
     ]
    },
    "radx_CancellationOfSharesToBeIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "CancellationOfSharesToBeIssued",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancellation of shares to be issued",
        "label": "Cancellation Of Shares To Be Issued",
        "documentation": "The amount of cancellation of shares to be issued."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CancellationOfTreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CancellationOfTreasuryShares",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancellation of shares to be issued relating to Lind",
        "label": "Cancellation of treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of treasury stock cancelled during the period. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "radx_CancerResearchTechnologyLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "CancerResearchTechnologyLimitedMember",
     "presentation": [
      "http://radx.com/20260630/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CRT [Member]",
        "label": "Cancer Research Technology Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_CapitalManagementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "CapitalManagementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Management [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash at bank and on hand",
        "label": "Cash"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails": {
       "parentTag": "radx_FinancialInstrumentsWithCashFlowRisk",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows",
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofCashandCashEquivalentsDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofConsolidatedStatementofCashFlowsDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash and cash equivalents",
        "verboseLabel": "Balances per statement of cash flows",
        "terseLabel": "Cash and cash equivalents",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the year",
        "periodEndLabel": "Cash and cash equivalents at end of the year",
        "label": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r62",
      "r87",
      "r176",
      "r258"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash proceeds from financing activities",
        "label": "Cash flows from (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r64"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash flows from (used in) financing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (payments)/proceeds from investing activities",
        "label": "Cash flows from (used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r64"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Cash flows from (used in) investing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails",
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net cash outflow from operating activities",
        "verboseLabel": "Net cash outflows from operations",
        "totalLabel": "Net cash payments from operating activities",
        "label": "Cash flows from (used in) operating activities"
       }
      }
     },
     "auth_ref": [
      "r56",
      "r64"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow Information [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r224"
     ]
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialLiabilitiesDomain",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of financial liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial liabilities. It also represents the standard value for the 'Categories of financial liabilities' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r145",
      "r224"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://radx.com/20260630/role/CommitmentsDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails",
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r200"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesDomain",
     "presentation": [
      "http://radx.com/20260630/role/CommitmentsDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails",
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r200"
     ]
    },
    "radx_ChangeInOperatingAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ChangeInOperatingAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in operating assets and liabilities:",
        "label": "Change In Operating Assets And Liabilities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "ifrs-full_ChangesInEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ChangesInEquity",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in equity",
        "label": "Increase (decrease) in equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "ifrs-full_ChangesInInvestmentProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ChangesInInvestmentProperty",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost",
        "label": "Increase (decrease) in investment property"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in investment property. [Refer: Investment property]"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r55",
      "r211",
      "r212"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfContingentLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfContingentLiabilitiesAxis",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r127",
      "r203"
     ]
    },
    "ifrs-full_ClassesOfContingentLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfContingentLiabilitiesDomain",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r127"
     ]
    },
    "ifrs-full_ClassesOfEmployeeBenefitsExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfEmployeeBenefitsExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Employee Benefit Obligations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r142",
      "r143",
      "r159",
      "r160",
      "r244"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsDomain",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r142",
      "r143",
      "r159",
      "r160",
      "r244"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r137",
      "r139",
      "r140",
      "r227",
      "r229"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r135",
      "r137",
      "r139",
      "r140",
      "r227",
      "r229"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r208"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillDomain",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r208"
     ]
    },
    "ifrs-full_ClassesOfLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfLiabilitiesAxis",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r233"
     ]
    },
    "ifrs-full_ClassesOfLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfLiabilitiesDomain",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r233"
     ]
    },
    "ifrs-full_ClassesOfOrdinarySharesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfOrdinarySharesAxis",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails",
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ifrs-full_ClassesOfOrdinarySharesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfOrdinarySharesDomain",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails",
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r190"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentDomain",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r190"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofOtherEquityDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r236",
      "r273"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalDomain",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofOtherEquityDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r236",
      "r273"
     ]
    },
    "radx_ClearingOfINDInTheUSOrAnyCountryInTerritoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ClearingOfINDInTheUSOrAnyCountryInTerritoryMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clearing of IND in the US or any country in Territory [member]",
        "label": "Clearing Of INDIn The USOr Any Country In Territory Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "radx_CommencementOfPhase3DiagnosticClinicalTrialFor68GaTRIVEHEXINDiagnosticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "CommencementOfPhase3DiagnosticClinicalTrialFor68GaTRIVEHEXINDiagnosticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commencement of Phase 3 diagnostic clinical trial for (68Ga-TRIVEHEXIN) (Diagnostic) [member]",
        "label": "Commencement Of Phase3 Diagnostic Clinical Trial For68 Ga TRIVEHEXINDiagnostic Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_CommercializationPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "CommercializationPayment",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon total worldwide Net Sales of all Licensed Products exceeding",
        "label": "Commercialization Payment",
        "documentation": "Commercialization payment."
       }
      }
     },
     "auth_ref": []
    },
    "radx_CommitmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "CommitmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_CommitmentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "CommitmentsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_CommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "CommitmentsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r388"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "ifrs-full_ComponentsOfEquityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityDomain",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncomealt2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetails",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total comprehensive loss",
        "totalLabel": "Total comprehensive loss for the year",
        "netLabel": "Comprehensive income",
        "terseLabel": "Total comprehensive income/(loss) for the year",
        "label": "Comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r73",
      "r85",
      "r202",
      "r214",
      "r246",
      "r277",
      "r296"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total comprehensive loss for the year is attributable to:",
        "label": "Comprehensive income attributable to [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncomealt2": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interests",
        "verboseLabel": "Loss allocated to non-controlling interests",
        "label": "Comprehensive income, attributable to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r246",
      "r278"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncomealt2": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Owners of Radiopharm Theranostics Limited",
        "label": "Comprehensive income, attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r246",
      "r279"
     ]
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Financial Statements [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ConsolidatedStatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ConsolidatedStatementOfChangesInEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statement Of Changes In Equity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ConsultingFeesRDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ConsultingFeesRDMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting Fees R&amp;D [Member]",
        "label": "Consulting Fees RDMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ConsultingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ConsultingMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting [Member]",
        "label": "Consulting Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ContingentConsiderationDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContingentConsiderationDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContingentConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration [Member]",
        "label": "Contingent consideration [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an obligation of the acquirer to transfer additional assets or equity interests to the former owners of an acquiree as part of the exchange for control of the acquiree if specified future events occur or conditions are met."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "radx_ContingentConsiderationScheduleofCommercializationPaymentsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContingentConsiderationScheduleofCommercializationPaymentsDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration - Schedule of Commercialization Payments (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ContingentConsiderationScheduleofCommercializationPaymentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContingentConsiderationScheduleofCommercializationPaymentsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration - Schedule of Commercialization Payments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration - Schedule of Commercialization Payments (Parentheticals) (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration - Schedule of Commercialization Payments (Parentheticals) (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Development Milestone Payments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration - Schedule of Development Milestone Payments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ContingentIssueOfEquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContingentIssueOfEquityMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofOtherEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent issue of equity [Member]",
        "label": "Contingent Issue Of Equity Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContractualCapitalCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContractualCapitalCommitments",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual commitments",
        "label": "Contractual capital commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]"
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "radx_ContractualMaturitiesOfFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContractualMaturitiesOfFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Contractual Maturities Of Financial Liabilities",
        "documentation": "Amount of contractual maturities of financial liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ContractualMaturitiesOfFinancialLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ContractualMaturitiesOfFinancialLiabilitiesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturities of Financial Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CorporateInformationAndStatementOfIFRSComplianceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Financial Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "negatedLabel": "Cost of sales",
        "label": "Cost of sales"
       }
      }
     },
     "auth_ref": [
      "r245",
      "r286"
     ]
    },
    "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CountryOfIncorporationOrResidenceOfSubsidiary",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Place of business/country of incorporation",
        "label": "Country of incorporation of subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r30",
      "r33",
      "r76",
      "r78"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CreationDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CreationDateAxis",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation date [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r179",
      "r180",
      "r181"
     ]
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrencyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrencyRiskMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Risk [Member]",
        "label": "Currency risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r111",
      "r146"
     ]
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets",
        "label": "Current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r265",
      "r296"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssetsLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current net assets",
        "label": "Current assets (liabilities)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets less the amount of current liabilities."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "negatedLabel": "Current liabilities",
        "terseLabel": "Current liabilities",
        "label": "Current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r266",
      "r296"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentProvisionsForEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentProvisionsForEmployeeBenefits",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofEmployeeBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Provisions (in Dollars)",
        "verboseLabel": "Current Leave obligations",
        "terseLabel": "Employee benefit obligations",
        "label": "Current provisions for employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r269"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofIncomeTaxExpenseDetails": {
       "parentTag": "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current tax on profits for the year",
        "label": "Current tax expense (income)"
       }
      }
     },
     "auth_ref": [
      "r287",
      "r315"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofIncomeTaxExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofIncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current tax expense",
        "label": "Current tax expense (income) and adjustments for current tax of prior periods"
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "radx_CustomerAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "CustomerAMember",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonMajorCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer A [Member]",
        "label": "Customer AMember"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Board of Directors Oversight [Text Block]",
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r338",
      "r422"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]",
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r334",
      "r418"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r333",
      "r417"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r333",
      "r417"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r333",
      "r417"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Third Party Engaged [Flag]",
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r335",
      "r419"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r337",
      "r421"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r337",
      "r421"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]",
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r336",
      "r420"
     ]
    },
    "ifrs-full_DateOfGrantOfSharebasedPaymentArrangement": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DateOfGrantOfSharebasedPaymentArrangement",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Date of options are granted",
        "label": "Date of grant of share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The date on which share-based payment arrangements are granted. [Refer: Types of share-based payment arrangements [domain]]"
       }
      }
     },
     "auth_ref": [
      "r303",
      "r304",
      "r316"
     ]
    },
    "ifrs-full_DefaultFinancialStatementsDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DefaultFinancialStatementsDateMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Default financial statements date [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Creation date' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r179",
      "r180",
      "r181"
     ]
    },
    "ifrs-full_DeferredIncomeIncludingContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredIncomeIncludingContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred income including contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities representing income that has been received (or the amount is due) but is not yet earned, including contract liabilities. [Refer: Contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r448",
      "r450"
     ]
    },
    "radx_DeferredPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DeferredPaymentMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Payment [Member]",
        "label": "Deferred Payment Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DefinedBenefitPlansAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansAxis",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit plans [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r191"
     ]
    },
    "ifrs-full_DefinedBenefitPlansDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansDomain",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit plans [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r191"
     ]
    },
    "radx_DepreciationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DepreciationsMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation [Member]",
        "label": "Depreciations [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_DescriptionOfAccountingPolicyForAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DescriptionOfAccountingPolicyForAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets classified as held for sale",
        "label": "Description Of Accounting Policy For Assets Or Disposal Groups Classified As Held For Sale Explanatory",
        "documentation": "The description of the entity's material accounting policy information for assets or disposal groups classified as held for sale."
       }
      }
     },
     "auth_ref": []
    },
    "radx_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of preparation",
        "label": "Description Of Accounting Policy For Basis Of Preparation Explanatory",
        "documentation": "The description of the entity's material accounting policy information for basis of preparation."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share",
        "label": "Description of accounting policy for earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classification and measurement of financial liabilities",
        "label": "Description of accounting policy for financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "label": "Description of accounting policy for foreign currency translation [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of assets",
        "label": "Description of accounting policy for impairment of assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the impairment of assets."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Description of accounting policy for intangible assets and goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIssuedCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIssuedCapitalExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributed equity",
        "label": "Description of accounting policy for issued capital [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for issued capital. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition",
        "label": "Description of accounting policy for recognition of revenue [text block]"
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other payables",
        "label": "Description of accounting policy for trade and other payables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "label": "Description of accounting policy for trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "radx_DescriptionOfAccountingPolicyInvestmentsAndOtherFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DescriptionOfAccountingPolicyInvestmentsAndOtherFinancialAssetsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments and other financial assets",
        "label": "Description Of Accounting Policy Investments And Other Financial Assets Explanatory",
        "documentation": "The description of the entity's material accounting policy information for investments and other financial assets."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r177"
     ]
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Expected volatility, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No. of options",
        "label": "Option life, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Risk free interest rate, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "radx_DiaprostContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DiaprostContingentConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diaprost Contingent Consideration\t[Member]",
        "label": "Diaprost Contingent Consideration Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted loss per share (in Dollars per share)",
        "label": "Diluted earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShareFromContinuingOperations",
     "presentation": [
      "http://radx.com/20260630/role/LossPerShareScheduleofReconciliationsofLossUsedinCalculatingLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted loss per share from continuing operations",
        "label": "Diluted earnings (loss) per share from continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Diluted earnings (loss) per share]"
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37"
     ]
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material estimates and judgements",
        "label": "Disclosure of accounting judgements and estimates [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Key Management Personnel Compensation",
        "label": "Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r196"
     ]
    },
    "ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Payable for Services by the Auditor [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Summarized Statement of Comprehensive Loss [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAssetsAndLiabilitiesWithSignificantRiskOfMaterialAdjustmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAssetsAndLiabilitiesWithSignificantRiskOfMaterialAdjustmentLineItems",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Estimates and Judgements [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Breakdown of Expenses by Nature [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAuditorsRemunerationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAuditorsRemunerationExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditors"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remuneration of auditors",
        "label": "Disclosure of auditors' remuneration [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of compensation to the entity's auditors."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBasisOfConsolidationExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/AccountingPoliciesbyPolicyPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of consolidation",
        "label": "Disclosure of basis of consolidation [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the basis used for consolidation."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parent entity financial information",
        "label": "Disclosure of basis of preparation of financial statements [text block]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "radx_DisclosureOfCapitalManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfCapitalManagementExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/CapitalManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital management",
        "label": "Disclosure Of Capital Management Explanatory",
        "documentation": "The disclosure of capital management."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Disclosure of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "radx_DisclosureOfCashFlowInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfCashFlowInformationExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow information",
        "label": "Disclosure Of Cash Flow Information Explanatory",
        "documentation": "The disclosure of cash flow information."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCashFlowStatementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCashFlowStatementExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Consolidated Statement of Cash Flows",
        "label": "Disclosure of cash flow statement [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for a statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingEstimatesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Estimates and Judgements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Capital",
        "label": "Disclosure of classes of share capital [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Classes of share capital [domain]]"
       }
      }
     },
     "auth_ref": [
      "r172",
      "r236",
      "r273"
     ]
    },
    "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/Commitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments",
        "label": "Disclosure of commitments and contingent liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Classes of contingent liabilities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsideration"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent consideration",
        "label": "Disclosure of contingent liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of contingent liabilities. [Refer: Classes of contingent liabilities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r42",
      "r203"
     ]
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCreditRiskExposureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCreditRiskExposureLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Exposure to Foreign Currency Risk [Line Items]",
        "terseLabel": "Schedule of Exposure to Interest Rate Risk [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Employee Benefit Obligations",
        "label": "Disclosure of defined benefit plans [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of defined benefit plans. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r191"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Intangible Assets",
        "label": "Disclosure of detailed information about intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r49",
      "r208"
     ]
    },
    "radx_DisclosureOfDevelopmentMilestonePaymentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfDevelopmentMilestonePaymentsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Development Milestone Payments",
        "label": "Disclosure Of Development Milestone Payments Explanatory",
        "documentation": "The disclosure of development milestone payments."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customers [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue from Contract with Customers",
        "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r162"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/LossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share",
        "label": "Disclosure of earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Exposure to Foreign Currency Risk",
        "label": "Disclosure of effect of changes in foreign exchange rates [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for the effect of changes in foreign exchange rates."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "ifrs-full_DisclosureOfExpensesByNatureExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfExpensesByNatureExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Breakdown of Expenses by Nature",
        "label": "Disclosure of expenses by nature [text block]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfExpensesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfExpensesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Expenses Arising from Share-Based Payment Transactions",
        "label": "Disclosure of expenses [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of expenses."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Liabilities with Significant Estimation Uncertainty",
        "label": "Disclosure of fair value measurement [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for fair value measurement."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Recurring Fair Value Measurements [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interests in Other Entities [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Financial Liabilities",
        "label": "Disclosure of financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r144",
      "r223"
     ]
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Financial Liabilities [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial risk management",
        "label": "Disclosure of financial risk management [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Statements",
        "label": "Disclosure of general information about financial statements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r254"
     ]
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Information on Geographical Regions",
        "label": "Disclosure of geographical areas [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ifrs-full_DisclosureOfGeographicalAreasLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasLineItems",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Information on Geographical Regions [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "radx_DisclosureOfIncomeTaxExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfIncomeTaxExpenseExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income Tax Expense",
        "label": "Disclosure Of Income Tax Expense Explanatory",
        "documentation": "The disclosure of income tax expense."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense",
        "label": "Disclosure of income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Model Inputs for Options Granted",
        "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInterestsInOtherEntitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInterestsInOtherEntitiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interests in other entities",
        "label": "Disclosure of interests in other entities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for interests in other entities."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ifrs-full_DisclosureOfIssuedCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIssuedCapitalExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Movements in Ordinary Shares",
        "label": "Disclosure of issued capital [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of issued capital. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfMajorCustomersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfMajorCustomersLineItems",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonMajorCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Information on Major Customers [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of material accounting policies",
        "label": "Disclosure of material accounting policy information [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure of material accounting policy information applied by the entity."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r240",
      "r252"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_DisclosureOfMovementsInOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfMovementsInOptionsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Movements in Options",
        "label": "Disclosure Of Movements In Options Explanatory",
        "documentation": "The disclosure of movements in options."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Events Occurring After the Reporting Year [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Events occurring after the reporting year [line items]",
        "label": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r183"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Employee Option Plan",
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r121",
      "r220"
     ]
    },
    "radx_DisclosureOfNumericalReconciliationOfIncomeTaxExpenseToPrimaFacieTaxPayableExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfNumericalReconciliationOfIncomeTaxExpenseToPrimaFacieTaxPayableExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable",
        "label": "Disclosure Of Numerical Reconciliation Of Income Tax Expense To Prima Facie Tax Payable Explanatory",
        "documentation": "The disclosure of numerical reconciliation of income tax expense to prima facie tax payable."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOffsettingOfFinancialAssetsAndFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-financial assets and liabilities",
        "label": "Disclosure of offsetting of financial assets and financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the offsetting of financial assets and financial liabilities. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment information",
        "label": "Disclosure of operating segments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "radx_DisclosureOfOtherEquityExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfOtherEquityExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Equity",
        "label": "Disclosure Of Other Equity Explanatory",
        "documentation": "The disclosure of other equity."
       }
      }
     },
     "auth_ref": []
    },
    "radx_DisclosureOfOtherIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfOtherIncomeTableTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other income",
        "label": "Disclosure Of Other Income Table Text Block",
        "documentation": "The tabular disclosure of other income."
       }
      }
     },
     "auth_ref": []
    },
    "radx_DisclosureOfOtherLossesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfOtherLossesTableTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Losses",
        "label": "Disclosure Of Other Losses Table Text Block",
        "documentation": "The tabular disclosure of other losses."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItems"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income and expense items",
        "label": "Disclosure of other operating income (expense) [text block]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfProductsAndServicesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfProductsAndServicesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Commercialization Payments",
        "label": "Disclosure of products and services [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's products and services. [Refer: Products and services [domain]]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ifrs-full_DisclosureOfProfitLossFromOperatingActivitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfProfitLossFromOperatingActivitiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Profit After Income Tax to Net Cash Inflow From Operating Activities",
        "label": "Disclosure of profit (loss) from operating activities [text block]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Options Outstanding",
        "label": "Disclosure of range of exercise prices of outstanding share options [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the range of exercise prices for outstanding share options."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Options Outstanding [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Financial Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets and financial liabilities",
        "label": "Disclosure of redesignated financial assets and liabilities [text block]"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ifrs-full_DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRedesignatedFinancialAssetsAndLiabilitiesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesDetails",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Assets and Financial Liabilities [Line Items]",
        "terseLabel": "Non-financial Assets and Liabilities [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party transactions",
        "label": "Disclosure of related party [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/EquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Statement of Financial Position Line Item \u2018Other Reserves\u2019 and the Movements in These Reserves During the Year and Period",
        "label": "Disclosure of reserves within equity [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of reserves within equity. [Refer: Other reserves [member]]"
       }
      }
     },
     "auth_ref": [
      "r173",
      "r237",
      "r274"
     ]
    },
    "ifrs-full_DisclosureOfReservesWithinEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReservesWithinEquityAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomers"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from contract with customers",
        "label": "Disclosure of revenue from contracts with customers [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102"
     ]
    },
    "ifrs-full_DisclosureOfSegmentsMajorCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSegmentsMajorCustomersExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Information on Major Customers",
        "label": "Disclosure of major customers [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of major customers."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/Equity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity",
        "label": "Disclosure of share capital, reserves and other equity interest [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r238",
      "r275"
     ]
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPayments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payments",
        "label": "Disclosure of share-based payment arrangements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Group\u2019s Subsidiaries",
        "label": "Disclosure of subsidiaries [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r32",
      "r35",
      "r91",
      "r230"
     ]
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Group\u2019s Subsidiaries [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Tax Losses",
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r188"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Tax Losses [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Employee Option Plan [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Trade and Other Payables",
        "label": "Disclosure of trade and other payables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Trade and Other Receivables",
        "label": "Disclosure of trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Transactions with Key Management Personnel",
        "label": "Disclosure of transactions between related parties [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r21",
      "r198"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Transactions with Key Management Personnel [Line Items]",
        "label": "Schedule of Transactions with Key Management Personal [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfVoluntaryChangeInAccountingPolicyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfVoluntaryChangeInAccountingPolicyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Material Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_DisclosureOfWeightedAverageNumberOfSharesUsedAsTheDenominatorExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "DisclosureOfWeightedAverageNumberOfSharesUsedAsTheDenominatorExplanatoryTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted Average Number of Shares Used as the Denominator",
        "label": "Disclosure Of Weighted Average Number Of Shares Used As The Denominator Explanatory Text Block",
        "documentation": "Disclosure of weighted average number of shares used as the denominator."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of discount rate",
        "label": "Discount rate used in current measurement of fair value less costs of disposal"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate used in the current measurement of fair value less costs of disposal."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ifrs-full_DividendsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DividendsPaid",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CapitalManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends paid",
        "label": "Dividends recognised as distributions to owners"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r239",
      "r251"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r349"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r349",
      "r392"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r331"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "radx_EMAApprovalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EMAApprovalMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EMA approval\t[member]",
        "label": "EMAApproval Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EURAUDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EURAUDMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EUR/AUD [Member]",
        "label": "EURAUDMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share for loss attributable to the ordinary equity holders of the group:",
        "label": "Loss Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareExplanatory",
     "presentation": [
      "http://radx.com/20260630/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliations of Loss Used in Calculating Loss Per Share",
        "label": "Earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effects of exchange rate changes on cash and cash equivalents",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58"
     ]
    },
    "radx_EmployeeBenefitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EmployeeBenefitMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee benefits [Member]",
        "label": "Employee Benefit [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EmployeeOptionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EmployeeOptionPlanMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Option Plan [Member]",
        "label": "Employee Option Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "terseLabel": "Total shareholders\u2019 equity",
        "label": "Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r72",
      "r92",
      "r93",
      "r94",
      "r201",
      "r213",
      "r231",
      "r232",
      "r243",
      "r262",
      "r270"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EQUITY",
        "verboseLabel": "Shareholders\u2019 equity",
        "label": "Equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofMovementsinOptionsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofMovementsinOptionsDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Movements in Options [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofMovementsinOptionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofMovementsinOptionsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity - Schedule of Movements in Options (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofMovementsinOrdinarySharesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofMovementsinOrdinarySharesDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Movements in Ordinary Shares [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofMovementsinOrdinarySharesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofMovementsinOrdinarySharesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity - Schedule of Movements in Ordinary Shares (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofMovementsinOrdinarySharesParentheticalsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofMovementsinOrdinarySharesParentheticalsDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Movements in Ordinary Shares [Line Items]",
        "label": "Equity Scheduleof Movementsin Ordinary Shares Parentheticals Details Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofMovementsinOrdinarySharesParentheticalsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofMovementsinOrdinarySharesParentheticalsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity - Schedule of Movements in Ordinary Shares (Parentheticals) (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofOtherEquityDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofOtherEquityDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofOtherEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Equity [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofOtherEquityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofOtherEquityDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofOtherEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity - Schedule of Other Equity (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Statement of Financial Position Line Item \u2018Other Reserves\u2019 and the Movements in These Reserves During the Year and Period [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity - Schedule of Statement of Financial Position Line Item \u2018Other Reserves\u2019 and the Movements in These Reserves During the Year and Period (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EquitySettledPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquitySettledPaymentsMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity settled payments [Member]",
        "label": "Equity Settled Payments Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "radx_EquivalentOfEitherOfTheseThatIsSufficientToAllowDosingInHumansInAnyCountryInTheTerritoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EquivalentOfEitherOfTheseThatIsSufficientToAllowDosingInHumansInAnyCountryInTheTerritoryMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equivalent of Either of These that is Sufficient to Allow Dosing in Humans in any Country in the Territory [Member]",
        "label": "Equivalent Of Either Of These That Is Sufficient To Allow Dosing In Humans In Any Country In The Territory Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r342",
      "r353",
      "r363",
      "r396"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r339",
      "r350",
      "r360",
      "r393"
     ]
    },
    "radx_EuroMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EuroMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Euro [Member]",
        "label": "Euro Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_EventsAfterReportingPeriodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "EventsAfterReportingPeriodMember",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events After Reporting Period [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ExchangeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ExchangeRate",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange rate",
        "label": "Exchange Rate",
        "documentation": "Exchange rate."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExercisePriceOfOutstandingShareOptions2019",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price (in Dollars per share)",
        "label": "Exercise price of outstanding share options"
       }
      },
      "en": {
       "role": {
        "documentation": "The exercise price of outstanding share options."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExercisePriceShareOptionsGranted2019",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price ($)\t(in Dollars per share)",
        "label": "Exercise price, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield",
        "label": "Expected dividend as percentage, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense for share-based payments for options previously issued, value",
        "label": "Expense from equity-settled share-based payment transactions"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofExpensesArisingfromShareBasedPaymentTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options issued",
        "label": "Expense from share-based payment transactions"
       }
      }
     },
     "auth_ref": [
      "r126",
      "r222"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Expenses Arising from Share-Based Payment Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ExpiryDateOfOutstandingShareOptions": {
     "xbrltype": "dateItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ExpiryDateOfOutstandingShareOptions",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiry date",
        "label": "Expiry Date Of Outstanding Share Options",
        "documentation": "The expiry date of outstanding share options."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExplanationOfFinancialEffectOfNonadjustingEventAfterReportingPeriod",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYear"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Events occurring after the reporting year",
        "label": "Explanation of financial effect of non-adjusting event after reporting period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The explanation of either an estimate of the financial effect of a non-adjusting event after the reporting period or a statement that such an estimate cannot be made."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r182"
     ]
    },
    "radx_ExposedForeignExchangeRiskPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ExposedForeignExchangeRiskPercentage",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exposed foreign exchange risk percentage",
        "label": "Exposed Foreign Exchange Risk Percentage",
        "documentation": "Exposed foreign exchange risk percentage."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ExposedInterestRateRisk": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ExposedInterestRateRisk",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exposed interest rate risk",
        "label": "Exposed Interest Rate Risk",
        "documentation": "Exposed interest rate risk."
       }
      }
     },
     "auth_ref": []
    },
    "radx_FDAApprovalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FDAApprovalMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FDA approval [member]",
        "label": "FDAApproval Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FDAINDAllowanceForATherapeuticProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FDAINDAllowanceForATherapeuticProductMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FDA IND allowance for a therapeutic product\t[member]",
        "label": "FDAINDAllowance For ATherapeutic Product Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FDASubmissionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FDASubmissionMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FDA submission [member]",
        "label": "FDASubmission Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FairValueAtGrantDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FairValueAtGrantDate",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value at grant date ($)\t(in Dollars)",
        "label": "Fair Value At Grant Date",
        "documentation": "The amount of fair value at grant date."
       }
      }
     },
     "auth_ref": []
    },
    "radx_FilingOfBLAorEquivalentInANonUSJurisdictionForALicensedProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FilingOfBLAorEquivalentInANonUSJurisdictionForALicensedProductMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Filing of BLA (or equivalent in a non-US jurisdiction) for a Licensed Product\t[member]",
        "label": "Filing Of BLAor Equivalent In ANon USJurisdiction For ALicensed Product Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Finance expenses",
        "label": "Finance costs"
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "radx_FinancialAssetsandFinancialLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialAssetsandFinancialLiabilitiesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Assets and Financial Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Assets and Financial Liabilities - Schedule of Financial Liabilities with Significant Estimation Uncertainty (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Assets and Financial Liabilities - Schedule of Other Financial Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Assets and Financial Liabilities - Schedule of Trade and Other Payables (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Assets and Financial Liabilities - Schedule of Trade and Other Receivables (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialInstrumentsWithCashFlowRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialInstrumentsWithCashFlowRisk",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Financial instruments with cash flow risk",
        "label": "Financial Instruments With Cash Flow Risk",
        "documentation": "Amount of financial instrument with cash flow risk."
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialInstrumentsWithCashFlowRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialInstrumentsWithCashFlowRiskAbstract",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments with cash flow risk",
        "label": "Financial Instruments With Cash Flow Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total financial liabilities",
        "label": "Financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "radx_FinancialLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialLiabilitiesAbstract",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Liabilities",
        "label": "Financial Liabilities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialRiskManagementDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialRiskManagementDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management - Schedule of Exposure to Foreign Currency Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management - Schedule of Exposure to Interest Rate Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management - Schedule of Impact of Foreign Currency Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management - Schedule of Impact of Foreign Currency Risk (Parentheticals) (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialRiskManagementScheduleofImpactofInterestRateRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialRiskManagementScheduleofImpactofInterestRateRiskDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management - Schedule of Impact of Interest Rate Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management - Schedule of Maturities of Financial Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FirstCommercialSaleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FirstCommercialSaleMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First commercial sale [member]",
        "label": "First Commercial Sale Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FirstPatientDosedInTheFirstPhase2TherapeuticClinicalTrialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FirstPatientDosedInTheFirstPhase2TherapeuticClinicalTrialMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First patient dosed in the first Phase 2 therapeutic clinical trial [member]",
        "label": "First Patient Dosed In The First Phase2 Therapeutic Clinical Trial Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FirstPatientDosedInTheFirstPhase3TherapeuticClinicalTrialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FirstPatientDosedInTheFirstPhase3TherapeuticClinicalTrialMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First patient dosed in the first Phase 3 therapeutic clinical trial [member]",
        "label": "First Patient Dosed In The First Phase3 Therapeutic Clinical Trial Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FirstPatientDosedInTheFirstPhase3TherapeuticClinicalTrialOrApprovalOfALicensedProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FirstPatientDosedInTheFirstPhase3TherapeuticClinicalTrialOrApprovalOfALicensedProductMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First patient dosed in the first Phase 3 therapeutic clinical trial, or approval of a Licensed Product [member]",
        "label": "First Patient Dosed In The First Phase3 Therapeutic Clinical Trial Or Approval Of ALicensed Product Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FirstPatientDosedInTheFirstPhaseOneTherapeuticClinicalTrialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FirstPatientDosedInTheFirstPhaseOneTherapeuticClinicalTrialMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First patient dosed in the first Phase 1 therapeutic clinical trial [member]",
        "label": "First Patient Dosed In The First Phase One Therapeutic Clinical Trial Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FirstPatientPhase3TherapeuticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FirstPatientPhase3TherapeuticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First patient Phase 3 (Therapeutic) [member]",
        "label": "First Patient Phase3 Therapeutic Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FirstPatientPhaseTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FirstPatientPhaseTwoMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First patient Phase 2 [member]",
        "label": "First Patient Phase Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FirstPatientPhaseTwoTherapeuticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FirstPatientPhaseTwoTherapeuticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First patient Phase 2 (Therapeutic)\t[member]",
        "label": "First Patient Phase Two Therapeutic Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_FirstPatientPivotalStudyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FirstPatientPivotalStudyMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First patient Pivotal Study [member]",
        "label": "First Patient Pivotal Study Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ForeignCurrencyTranslationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ForeignCurrencyTranslationMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation [Member]",
        "label": "Foreign Currency Translation Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ForeignOperationsWhoseFunctionalCurrencyIsNotExchangeableIntoPresentationCurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ForeignOperationsWhoseFunctionalCurrencyIsNotExchangeableIntoPresentationCurrencyAxis",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign operations whose functional currency is not exchangeable into presentation currency [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r194"
     ]
    },
    "ifrs-full_ForeignOperationsWhoseFunctionalCurrencyIsNotExchangeableIntoPresentationCurrencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ForeignOperationsWhoseFunctionalCurrencyIsNotExchangeableIntoPresentationCurrencyDomain",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign operations whose functional currency is not exchangeable into presentation currency [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value of the \u2018Foreign operations whose functional currency is not exchangeable into presentation currency\u2019 axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r194"
     ]
    },
    "radx_ForfeiturePaymentsExpenseToKeyManagementPersonnelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ForfeiturePaymentsExpenseToKeyManagementPersonnelMember",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeiture payments expense to key management personnel [Member]",
        "label": "Forfeiture Payments Expense To Key Management Personnel Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ForfeitureSharesAsPerEmploymentContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ForfeitureSharesAsPerEmploymentContractMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeiture shares as per employment contract [Member]",
        "label": "Forfeiture Shares As Per Employment Contract Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ForfeitureSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ForfeitureSharesMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeiture shares [Member]",
        "label": "Forfeiture Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r367",
      "r400"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r367",
      "r400"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r367",
      "r400"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r367",
      "r400"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r367",
      "r400"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "radx_FrankingAccountBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FrankingAccountBalance",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/CapitalManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Franking account balance",
        "label": "Franking Account Balance",
        "documentation": "Franking account balance."
       }
      }
     },
     "auth_ref": []
    },
    "radx_FullAmountOfAccruedLeaveOrRequirePayment": {
     "xbrltype": "durationItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "FullAmountOfAccruedLeaveOrRequirePayment",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued leave or require payment",
        "label": "Full Amount Of Accrued Leave Or Require Payment",
        "documentation": "It represents employees full amount of accrued leave or require payment ."
       }
      }
     },
     "auth_ref": []
    },
    "radx_GBPAUDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "GBPAUDMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GBP/AUD [Member]",
        "label": "GBPAUDMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_GBPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "GBPMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GBP [Member]",
        "label": "GBPMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnChangeInFairValueOfDerivatives",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain/(loss) on movement in contingent consideration",
        "label": "Gains (losses) on change in fair value of derivatives"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation differences",
        "label": "Gains (losses) on exchange differences on translation of foreign operations, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofOtherLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net foreign exchange gains/(losses)",
        "label": "Foreign exchange gain (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r192",
      "r253"
     ]
    },
    "ifrs-full_GainsOnDisposalsOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsOnDisposalsOfPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofOtherLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on sale of available-for-sale assets",
        "label": "Gains on disposals of property, plant and equipment"
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "General and administrative expenses",
        "terseLabel": "General and administrative expenses",
        "label": "General and administrative expense"
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetails",
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r288",
      "r300",
      "r302",
      "r314"
     ]
    },
    "ifrs-full_GeographicalAreasDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasDomain",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetails",
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r288",
      "r300",
      "r302",
      "r314"
     ]
    },
    "radx_GoingConcernMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "GoingConcernMember",
     "presentation": [
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Going concern [Member]",
        "label": "Going Concern Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_GrantDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "GrantDateAxis",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails",
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant Date [Axis]",
        "label": "Grant Date Axis"
       }
      }
     },
     "auth_ref": []
    },
    "radx_GrantDateDomainDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "GrantDateDomainDomain",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails",
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GrantDateDomain [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_GrantOfEUorUKRegulatoryApprovalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "GrantOfEUorUKRegulatoryApprovalMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant of EU (or UK) Regulatory Approval [member]",
        "label": "Grant Of EUor UKRegulatory Approval Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_GrantOfMAInTheEUorUKMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "GrantOfMAInTheEUorUKMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant of MA in the EU (or UK) [member]",
        "label": "Grant Of MAIn The EUor UKMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_GrantOfUSRegulatoryApprovalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "GrantOfUSRegulatoryApprovalMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant of US Regulatory Approval [member]",
        "label": "Grant Of USRegulatory Approval Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross Profit",
        "label": "Gross profit"
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "radx_Guarantees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Guarantees",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantees",
        "label": "Guarantees",
        "documentation": "Represents the amount of guarantees."
       }
      }
     },
     "auth_ref": []
    },
    "radx_INDAllowanceByTheUSFDAOrTheEMAOrTheNMPAforEitherTheHER2OrTheTROP2TherapeuticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "INDAllowanceByTheUSFDAOrTheEMAOrTheNMPAforEitherTheHER2OrTheTROP2TherapeuticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IND allowance by the U.S. FDA or the EMA or the NMPA (for either the HER-2 or the TROP-2 Therapeutic) [member]",
        "label": "INDAllowance By The USFDAOr The EMAOr The NMPAfor Either The HER2 Or The TROP2 Therapeutic Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_INDAllowanceByTheUSFDAOrTheEMAOrTheNMPAforThePKT7TherapeuticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "INDAllowanceByTheUSFDAOrTheEMAOrTheNMPAforThePKT7TherapeuticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IND allowance by the U.S. FDA or the EMA or the NMPA (for the PKT-7 Therapeutic) [member]",
        "label": "INDAllowance By The USFDAOr The EMAOr The NMPAfor The PKT7 Therapeutic Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_INDSubmissionToTheUSFDAOrTheEMAOrTheNMPAForPDL1TherapeuticBindingLicenseAgreementWithAThirdpartyToImproveCamelidPDL1TherapeuticIndexMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "INDSubmissionToTheUSFDAOrTheEMAOrTheNMPAForPDL1TherapeuticBindingLicenseAgreementWithAThirdpartyToImproveCamelidPDL1TherapeuticIndexMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IND submission to the U.S. FDA or the EMA or the NMPA for PDL-1 Therapeutic) \u2013 binding license agreement with a third-party to improve Camelid PDL-1 therapeutic index [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_INDSubmissionToTheUSFDAOrTheEMAOrTheNMPAForPDL1TherapeuticINDSubmissionForTheCamelidPDL1NewFormulationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "INDSubmissionToTheUSFDAOrTheEMAOrTheNMPAForPDL1TherapeuticINDSubmissionForTheCamelidPDL1NewFormulationMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IND submission to the U.S. FDA or the EMA or the NMPA for PDL-1 Therapeutic) - IND submission for the Camelid PDL-1 New Formulation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r330",
      "r331",
      "r349"
     ]
    },
    "radx_ImpactOfForeignCurrencyRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ImpactOfForeignCurrencyRiskLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Impact of Foreign Currency Risk [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ImpactOfInterestRateRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ImpactOfInterestRateRiskLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Impact of Interest Rate Risk [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ImpactOnOtherComponentsOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ImpactOnOtherComponentsOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact on other components of equity",
        "label": "Impact On Other Components Of Equity",
        "documentation": "Amount of impact on other components of equity."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ImpactOnPosttaxLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ImpactOnPosttaxLoss",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact on post-tax loss",
        "label": "Impact On Posttax Loss",
        "documentation": "Amount of impact on post-tax loss."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment charge",
        "label": "Impairment loss recognised in profit or loss, intangible assets other than goodwill"
       }
      }
     },
     "auth_ref": [
      "r44",
      "r204"
     ]
    },
    "radx_ImpairmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ImpairmentMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment [Member]",
        "label": "Impairment Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ImpairmentOnOtherEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ImpairmentOnOtherEquity",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment \u2013 Pharma 15",
        "label": "Impairment on Other Equity",
        "documentation": "Amount of Impairment on other equity."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofIncomeTaxExpenseDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense",
        "negatedLabel": "Income tax expense",
        "totalLabel": "Income tax expense",
        "label": "Tax expense (income)"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r29",
      "r90",
      "r149",
      "r184",
      "r185",
      "r186",
      "r282"
     ]
    },
    "radx_IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense - Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense - Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable (Parentheticals) (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_IncomeTaxExpenseScheduleofTaxLossesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncomeTaxExpenseScheduleofTaxLossesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense - Schedule of Tax Losses (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense - Schedule of Tax Losses (Parentheticals) (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (Decrease)/Increase in cash and cash equivalents",
        "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r62",
      "r176"
     ]
    },
    "radx_IncreaseDecreaseInSharesAsPartOfLicenseAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncreaseDecreaseInSharesAsPartOfLicenseAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares as part of license acquisition",
        "label": "Increase Decrease In Shares As Part Of License Acquisition",
        "documentation": "Increase (decrease) in shares as part of license acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IncreaseDecreaseThroughExpirationOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncreaseDecreaseThroughExpirationOfOptions",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration of options",
        "label": "Increase Decrease Through Expiration Of Options",
        "documentation": "The increase (decrease) in equity resulting from the expiration of options."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IncreaseDecreaseThroughForfeitureOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncreaseDecreaseThroughForfeitureOfOptions",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeiture of options",
        "label": "Increase Decrease Through Forfeiture Of Options",
        "documentation": "The increase (decrease) in equity resulting from the forfeiture of options."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IncreaseDecreaseThroughIssueOfOptionsAsPartOfForfeiturePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncreaseDecreaseThroughIssueOfOptionsAsPartOfForfeiturePayments",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of options as part of forfeiture payments",
        "label": "Increase Decrease Through Issue Of Options As Part Of Forfeiture Payments",
        "documentation": "The increase (decrease) in the entity's equity resulting from the issue of options as part of forfeiture payments."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IncreaseDecreaseThroughIssueOfSharesAsPartOfForfeiturePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncreaseDecreaseThroughIssueOfSharesAsPartOfForfeiturePayments",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares as part of forfeiture payments",
        "label": "Increase Decrease Through Issue Of Shares As Part Of Forfeiture Payments",
        "documentation": "The increase (decrease) in the entity's equity resulting from the issue of shares as part of forfeiture payments."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IncreaseDecreaseThroughIssueOfSharesAsPartOfPlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncreaseDecreaseThroughIssueOfSharesAsPartOfPlacement",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares as part of placement",
        "label": "Increase Decrease Through Issue Of Shares As Part Of Placement",
        "documentation": "The increase (decrease) in the entity's equity resulting from the issue of shares as part of placement."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IncreaseDecreaseThroughLapseOfForfeiturePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncreaseDecreaseThroughLapseOfForfeiturePayment",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lapse of forfeiture payment",
        "label": "Increase Decrease Through Lapse Of Forfeiture Payment",
        "documentation": "The increase (decrease) in the entity's equity resulting from the lapse of forfeiture payment."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange differences",
        "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesInvestmentProperty",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange difference",
        "label": "Increase (decrease) through net exchange differences, investment property"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in investment property resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Investment property]"
       }
      }
     },
     "auth_ref": [
      "r52",
      "r54"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughOtherChangesIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization charge",
        "label": "Increase (decrease) through other changes, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r206"
     ]
    },
    "radx_IncreaseDecreaseThroughOtherThanGoodwillSaleOfAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncreaseDecreaseThroughOtherThanGoodwillSaleOfAsset",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of asset(note 6(a)",
        "label": "Increase Decrease Through Other Than Goodwill Sale Of Asset",
        "documentation": "It represents sale of asset."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-settled payments",
        "label": "Increase (decrease) through share-based payment transactions, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r248"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransactionsWithOwners",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions of equity net of transaction costs",
        "label": "Increase (decrease) through transactions with owners, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from transactions with owners."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTreasuryShareTransactions",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares per the share purchase agreement",
        "label": "Increase (decrease) through treasury share transactions, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r249"
     ]
    },
    "radx_IncreaseInOwnershipInRADVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IncreaseInOwnershipInRADVentures",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in ownership in RAD Ventures",
        "label": "Increase In Ownership In RADVentures",
        "documentation": "Increase in ownership in RAD Ventures."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r367",
      "r391",
      "r400",
      "r404",
      "r412"
     ]
    },
    "radx_InitiationOfPhaseIClinicalTrialOfALicensedProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InitiationOfPhaseIClinicalTrialOfALicensedProductMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initiation of Phase I Clinical Trial of a Licensed Product\t[member]",
        "label": "Initiation Of Phase IClinical Trial Of ALicensed Product Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_InitiationOfPhaseIIClinicalTrialOfALicensedProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InitiationOfPhaseIIClinicalTrialOfALicensedProductMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initiation of Phase II Clinical Trial of a Licensed Product [member]",
        "label": "Initiation Of Phase IIClinical Trial Of ALicensed Product Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_InitiationOfPhaseIIIClinicalTrialOfALicensedProductMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InitiationOfPhaseIIIClinicalTrialOfALicensedProductMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initiation of Phase III Clinical Trial of a Licensed Product [member]",
        "label": "Initiation Of Phase IIIClinical Trial Of ALicensed Product Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r332",
      "r416"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r332",
      "r416"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r332",
      "r416"
     ]
    },
    "radx_InsuranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InsuranceMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance [Member]",
        "label": "Insurance Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsMaterialToEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsMaterialToEntityAxis",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets material to entity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r209"
     ]
    },
    "ifrs-full_IntangibleAssetsMaterialToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsMaterialToEntityDomain",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets material to entity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets material to the entity. It also represents the standard value for the 'Intangible assets material to entity' axis if no other member is used. [Refer: Intangible assets material to entity]"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r209"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Closing net book amount",
        "periodStartLabel": "Opening net book amount",
        "verboseLabel": "Net book amount",
        "terseLabel": "Intangible assets",
        "label": "Intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r207",
      "r256"
     ]
    },
    "ifrs-full_InterestCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestCostsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interests in Other Entities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_InterestIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InterestIncome",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofOtherincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income",
        "documentation": "Amount of interest income."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest rate risk [member]",
        "terseLabel": "Interest Rate Risk [Member]",
        "label": "Interest rate risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r111",
      "r146"
     ]
    },
    "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestReceivedClassifiedAsOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest received",
        "label": "Interest received, classified as operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "radx_InterestsinOtherEntitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InterestsinOtherEntitiesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interests in Other Entities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interests in Other Entities - Schedule of Group\u2019s Subsidiaries (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Summarized Balance Sheet [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interests in Other Entities - Schedule of Summarized Balance Sheet (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interests in Other Entities - Schedule of Summarized Statement of Comprehensive Loss (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_InvestorRelationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "InvestorRelationsMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investor relations [Member]",
        "label": "Investor Relations Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssueOfConvertibleInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssueOfConvertibleInstruments",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of options",
        "label": "Issue of convertible instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The change in equity resulting from the issuing of convertible instruments."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "ifrs-full_IssueOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssueOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of options",
        "verboseLabel": "Processed amount",
        "label": "Issue of equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r248"
     ]
    },
    "radx_IssueOfEquityGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IssueOfEquityGross",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions of equity",
        "label": "Issue Of Equity Gross",
        "documentation": "Issue of equity, gross before deducting transaction costs."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IssueOfListedOptionsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IssueOfListedOptionsValue",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of listed options, value",
        "label": "Issue Of Listed Options Value",
        "documentation": "Issue of listed options, value."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IssueOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IssueOfOrdinaryShares",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of ordinary shares (in Shares)",
        "label": "Issue Of Ordinary Shares",
        "documentation": "Number of issue of ordinary shares."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IssueOfOrdinarySharesValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IssueOfOrdinarySharesValue",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of ordinary shares value",
        "label": "Issue Of Ordinary Shares Value",
        "documentation": "The amount of the issue of ordinary shares."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IssueOfPlacementSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IssueOfPlacementSharesMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of placement shares [Member]",
        "label": "Issue Of Placement Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_IssueOfPlacementSharesToLantheusMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IssueOfPlacementSharesToLantheusMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of placement shares to Lantheus [Member]",
        "label": "Issue Of Placement Shares To Lantheus Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_IssueOfSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IssueOfSecuritiesMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of securities [Member]",
        "label": "Issue Of Securities Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_IssueOfSharesForMilestoneCompletion": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IssueOfSharesForMilestoneCompletion",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares for milestone completion",
        "label": "Issue Of Shares For Milestone Completion",
        "documentation": "The amount of issue of shares for milestone completion."
       }
      }
     },
     "auth_ref": []
    },
    "radx_IssueOfSharesInLieuOfServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "IssueOfSharesInLieuOfServices",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of shares in lieu of services",
        "label": "Issue Of Shares In Lieu Of Services",
        "documentation": "Issue of shares in lieu of services."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital",
        "verboseLabel": "Issued capital",
        "label": "Issued capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r324"
     ]
    },
    "ifrs-full_IssuedCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital",
        "label": "Issued capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "ifrs-full_IssuedCapitalOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalOrdinaryShares",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning",
        "periodEndLabel": "Balance at ending",
        "terseLabel": "Shares to be issued",
        "label": "Issued capital, ordinary shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Key management personnel compensation"
       }
      }
     },
     "auth_ref": [
      "r19",
      "r195"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationOtherLongtermBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationOtherLongtermBenefits",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term benefits",
        "label": "Key management personnel compensation, other long-term employee benefits"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Post-employment benefits",
        "label": "Key management personnel compensation, post-employment benefits"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments",
        "label": "Key management personnel compensation, share-based payment"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofKeyManagementPersonnelCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term employee benefits",
        "label": "Key management personnel compensation, short-term employee benefits"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "radx_KeyManagementPersonnelForfeiturePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "KeyManagementPersonnelForfeiturePayments",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Key management personnel forfeiture payments",
        "label": "Key Management Personnel Forfeiture Payments",
        "documentation": "Key management personnel, forfeiture payments."
       }
      }
     },
     "auth_ref": []
    },
    "radx_LantheusInvestmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "LantheusInvestmentMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lantheus investment [Member]",
        "label": "Lantheus Investment Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_LastPatientPhaseOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "LastPatientPhaseOneMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Last patient Phase 1 [member]",
        "label": "Last Patient Phase One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_LastPatientPhaseOneTherapeuticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "LastPatientPhaseOneTherapeuticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Last patient Phase 1 (Therapeutic) [member]",
        "label": "Last Patient Phase One Therapeutic Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_LastPatientPhaseThreeTherapeuticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "LastPatientPhaseThreeTherapeuticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Last patient Phase 3 (Therapeutic)\t[member]",
        "label": "Last Patient Phase Three Therapeutic Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_LastPatientPhaseTwoBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "LastPatientPhaseTwoBMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Last patient Phase 2B [member]",
        "label": "Last Patient Phase Two BMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_LastPatientPhaseTwoTherapeuticMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "LastPatientPhaseTwoTherapeuticMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Last patient Phase 2 (Therapeutic)\t[member]",
        "label": "Last Patient Phase Two Therapeutic Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "radx_LegalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "LegalMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal [Member]",
        "label": "Legal Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_NetAssetsLiabilities",
       "weight": -1.0,
       "order": 2.0
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r150",
      "r154",
      "r231",
      "r232",
      "r262"
     ]
    },
    "ifrs-full_LicenceFeeIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LicenceFeeIncome",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License fee payable",
        "label": "Licence fee income"
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "radx_LieuOfCashForServicesRenderedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "LieuOfCashForServicesRenderedMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lieu of cash for services rendered [Member]",
        "label": "Lieu Of Cash For Services Rendered Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_LindAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "LindAgreementMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lind agreement [Member]",
        "label": "Lind Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ListingAndShareRegistryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ListingAndShareRegistryMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Listing and share registry [Member]",
        "label": "Listing And Share Registry Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "radx_MAbMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "MAbMember",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MAb [Member]",
        "label": "MAb Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_MDAndersonContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "MDAndersonContingentConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MD Anderson Contingent Consideration [Member]",
        "label": "MDAnderson Contingent Consideration Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_MDAndersonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "MDAndersonMember",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MD Anderson [Member]",
        "label": "MDAnderson Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorComponentsOfTaxExpenseIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonMajorCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major customers [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ifrs-full_MajorCustomersDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorCustomersDomain",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonMajorCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major customers [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "radx_MaterialEstimatesandJudgementsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "MaterialEstimatesandJudgementsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Estimates and Judgements (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r113",
      "r130",
      "r141",
      "r161",
      "r163",
      "r165",
      "r167",
      "r225",
      "r264",
      "r289",
      "r307"
     ]
    },
    "ifrs-full_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityDomain",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r113",
      "r130",
      "r161",
      "r163",
      "r165",
      "r167",
      "r225",
      "r264",
      "r289",
      "r307",
      "r308"
     ]
    },
    "ifrs-full_MaximumExposureToCreditRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaximumExposureToCreditRisk",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total exposure",
        "label": "Maximum exposure to credit risk"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that best represents the maximum exposure to credit risk without taking into account any collateral held or other credit enhancements (for example, netting agreements that do not qualify for offset in accordance with IAS 32). [Refer: Credit risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "radx_MaximumOverdueDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "MaximumOverdueDays",
     "presentation": [
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum overdue days",
        "label": "Maximum Overdue Days",
        "documentation": "Maximum overdue days."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "radx_MileStonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "MileStonePayments",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone payment",
        "label": "Mile Stone Payments",
        "documentation": "It represents amount of payment related to milestones."
       }
      }
     },
     "auth_ref": []
    },
    "radx_MilestonePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "MilestonePaymentsMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone payments [Member]",
        "label": "Milestone Payments Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Milestonepayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Milestonepayment",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Milestone\tpayment",
        "label": "Milestonepayment",
        "documentation": "Represent the amount of milestone payments."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "radx_NanoMabContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NanoMabContingentConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NanoMab Contingent Consideration [Member]",
        "label": "Nano Mab Contingent Consideration Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_NanoMabIntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NanoMabIntellectualPropertyMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NanoMab intellectual property [member]",
        "label": "Nano Mab Intellectual Property Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_NanoMabMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NanoMabMember",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NanoMab [Member]",
        "label": "Nano Mab Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_NanoMabTechnologyLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NanoMabTechnologyLimitedMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NanoMab Technology Limited [member]",
        "label": "Nano Mab Technology Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_NeoIndicateContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NeoIndicateContingentConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NeoIndicate Contingent Consideration [Member]",
        "label": "Neo Indicate Contingent Consideration Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_NeoindicateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NeoindicateMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Neoindicate [Member]",
        "label": "Neoindicate Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetAssetsLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net assets",
        "label": "Assets (liabilities)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of liabilities."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r446"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "radx_NetSalesOfAllLicensedProductsExceedingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NetSalesOfAllLicensedProductsExceedingValue",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net sales of all licensed products exceeding value",
        "label": "Net Sales Of All Licensed Products Exceeding Value",
        "documentation": "Net sales of all licensed products exceeding value."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NineTwelveTwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NineTwelveTwoThousandTwentyFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-12-09 [Member]",
        "label": "Nine Twelve Two Thousand Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r346",
      "r357",
      "r367",
      "r391",
      "r400"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r183"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodDomain",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r183"
     ]
    },
    "ifrs-full_NoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accumulated non-controlling interests",
        "terseLabel": "Non-controlling interests",
        "label": "Non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r261"
     ]
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncontrollingInterestsMember",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interests",
        "label": "Non-controlling interests [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "terseLabel": "Non-current assets",
        "label": "Non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r265",
      "r296"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current assets",
        "label": "Non-current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "terseLabel": "Non-current liabilities",
        "label": "Non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r266",
      "r296"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current liabilities",
        "label": "Non-current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_NoncurrentNetAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NoncurrentNetAssets",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Non-current net assets",
        "label": "Noncurrent Net Assets",
        "documentation": "Represents the amount of non-current net assets."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other payables",
        "verboseLabel": "Trade and other payables, Non- current",
        "label": "Trade and other non-current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]"
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_NoncurrentProvisionsForEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentProvisionsForEmployeeBenefits",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofEmployeeBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non- current Leave obligations",
        "label": "Non-current provisions for employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r269"
     ]
    },
    "ifrs-full_NoncurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentReceivables",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other receivables Non-Current, Total",
        "label": "Trade and other non-current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r257",
      "r268"
     ]
    },
    "radx_Nonderivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Nonderivatives",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-derivatives",
        "label": "Nonderivatives",
        "documentation": "Amount of non-derivatives."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NonfinancialAssetsandLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NonfinancialAssetsandLiabilitiesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-financial Assets and Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-financial Assets and Liabilities - Schedule of Intangible Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotLaterThanOneYearMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "6 - 12 months [Member]",
        "label": "Not later than one year [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104",
      "r113",
      "r164",
      "r166",
      "r263",
      "r307",
      "r310"
     ]
    },
    "radx_NotLaterThanSixMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NotLaterThanSixMonthsMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less than 6 months [Member]",
        "label": "Not Later Than Six Months Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfExpirationOfOptionsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfExpirationOfOptionsValue",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expiration of options, value",
        "label": "Number Of Expiration Of Options Value",
        "documentation": "Represent the amount of expiration of options value."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfForfeitureOfOptionsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfForfeitureOfOptionsValue",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeiture of options, value",
        "label": "Number Of Forfeiture Of Options Value",
        "documentation": "Represent the amount of forfeiture of options value."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfIssueOfESOPUnlistedOptionsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfIssueOfESOPUnlistedOptionsValue",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of ESOP unlisted options, value",
        "label": "Number Of Issue Of ESOPUnlisted Options Value",
        "documentation": "Represent the amount of issue of ESOP unlisted options, value."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfIssueOfUnlistedOptionsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfIssueOfUnlistedOptionsValue",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of unlisted options, value",
        "label": "Number Of Issue Of Unlisted Options Value",
        "documentation": "Represent the amount of issue of unlisted options."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfOptionsGrantedExpiryDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfOptionsGrantedExpiryDate",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiry date",
        "label": "Number Of Options Granted Expiry Date",
        "documentation": "The options granted for expired date."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfOptionsVestedAndExercisable": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfOptionsVestedAndExercisable",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, Vested and exercisable",
        "label": "Number Of Options Vested And Exercisable",
        "documentation": "The number of share options vested and exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails",
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance ,share",
        "periodEndLabel": "Ending balance, share",
        "terseLabel": "Share options",
        "label": "Number of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r120",
      "r122",
      "r215",
      "r219"
     ]
    },
    "radx_NumberOfOutstandingShareOptionsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfOutstandingShareOptionsValue",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "label": "Number Of Outstanding Share Options Value",
        "documentation": "Represent the amount of shares option for other reserves."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfReportablesSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfReportablesSegments",
     "presentation": [
      "http://radx.com/20260630/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segment",
        "label": "Number Of Reportables Segments",
        "documentation": "Number of reportable segments."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfShareOptionsExpenseForSharebasedPaymentsForOptionsPreviouslyIssuedShares": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfShareOptionsExpenseForSharebasedPaymentsForOptionsPreviouslyIssuedShares",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense for share-based payments for options previously issued, shares",
        "label": "Number Of Share Options Expense For Sharebased Payments For Options Previously Issued Shares",
        "documentation": "The number of share options expense for share-based payments for options previously issued."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expiration of options ,share",
        "label": "Number of share options expired in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options expired in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r218"
     ]
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails",
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeiture of options, share",
        "negatedTerseLabel": "Number of options, Forfeited during the year",
        "label": "Number of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r217"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, Granted during the year",
        "label": "Number of share options granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r216"
     ]
    },
    "radx_NumberOfShareOptionsIssueOfESOPUnlistedOptionsShares": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfShareOptionsIssueOfESOPUnlistedOptionsShares",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of ESOP unlisted options, shares",
        "label": "Number Of Share Options Issue Of ESOPUnlisted Options Shares",
        "documentation": "he number of share options issue of ESOP unlisted options."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfShareOptionsIssueOfUnlistedOptionsShares": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfShareOptionsIssueOfUnlistedOptionsShares",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of unlisted options, shares",
        "label": "Number Of Share Options Issue Of Unlisted Options Shares",
        "documentation": "he number of share options issue of unlisted options, shares."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfShareOptionsIssueOflistedOptionsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfShareOptionsIssueOflistedOptionsShares",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of listed options, share (in Shares)",
        "label": "Number Of Share Options Issue Oflisted Options Shares",
        "documentation": "he number of share options issue of listed options, shares."
       }
      }
     },
     "auth_ref": []
    },
    "radx_NumberOfSharesEmployeeOptionPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "NumberOfSharesEmployeeOptionPlan",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of options, Ending balance (in Shares)",
        "periodStartLabel": "Number of options, Beginning balance\t(in Shares)",
        "label": "Number Of Shares Employee Option Plan",
        "documentation": "Number of shares in the employee option plan."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning (in Shares)",
        "periodEndLabel": "Balance at ending (in Shares)",
        "terseLabel": "Ordinary shares",
        "label": "Number of shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "ifrs-full_NumberOfSharesIssuedAndFullyPaid": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfSharesIssuedAndFullyPaid",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares Fully paid, shares",
        "label": "Number of shares issued and fully paid"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity, for which full payment has been received."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r234",
      "r271"
     ]
    },
    "radx_OIPPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OIPPlanMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OIP Plan [Member]",
        "label": "OIPPlan Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OneZeroEightTwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OneZeroEightTwoThousandTwentyFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-08-01 [Member]",
        "label": "One Zero Eight Two Thousand Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OneZeroSevenTwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OneZeroSevenTwoThousandTwentyFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-07-01 [Member]",
        "label": "One Zero Seven Two Thousand Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OneZeroSixTwoThousandTwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OneZeroSixTwoThousandTwentySixMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026-06-01 [Mmeber]",
        "label": "One Zero Six Two Thousand Twenty Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OptionsForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OptionsForfeited",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeiture of options",
        "label": "Options Forfeited",
        "documentation": "Options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "radx_OrdinarySharesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OrdinarySharesAbstract",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "label": "Ordinary Shares Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OrdinarySharesFullyPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OrdinarySharesFullyPaid",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares Fully paid, value",
        "label": "Ordinary Shares Fully Paid",
        "documentation": "Amount of ordinary shares fully paid."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares [Member]",
        "label": "Ordinary shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "radx_OrdinarySharesValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OrdinarySharesValue",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofShareCapitalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares value",
        "label": "Ordinary Shares Value",
        "documentation": "Amount of ordinary shares."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income/(loss)",
        "label": "Schedule of Other Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncomeBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income",
        "label": "Other comprehensive income, before tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, before tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other comprehensive loss",
        "terseLabel": "Exchange differences on translation of foreign operations",
        "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r267",
      "r283"
     ]
    },
    "ifrs-full_OtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "verboseLabel": "Net current assets",
        "label": "Other current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "ifrs-full_OtherCurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCurrentFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial liabilities",
        "verboseLabel": "Other financial liabilities, Current",
        "label": "Other current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r260"
     ]
    },
    "ifrs-full_OtherEquityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherEquityInterest",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      },
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/EquityScheduleofOtherEquityDetails",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total issue of other equity",
        "terseLabel": "Other equity",
        "netLabel": "Total",
        "label": "Other equity interest"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity interest of an entity without share capital that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r324"
     ]
    },
    "ifrs-full_OtherEquityInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherEquityInterestMember",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other equity",
        "label": "Other equity interest [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity interest of an entity without share capital that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "ifrs-full_OtherExpenseByFunction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherExpenseByFunction",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofOtherLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other losses",
        "negatedTerseLabel": "Total",
        "label": "Other expense, by function"
       }
      }
     },
     "auth_ref": [
      "r28",
      "r286",
      "r321"
     ]
    },
    "ifrs-full_OtherFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other financial liabilities",
        "terseLabel": "Other financial liabilities, Total",
        "label": "Other financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofOtherincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Other income",
        "label": "Other income"
       }
      }
     },
     "auth_ref": [
      "r27",
      "r320",
      "r321"
     ]
    },
    "radx_OtherIncomeAndExpenseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OtherIncomeAndExpenseLineItems",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expense Items [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OtherIncomeandExpenseItemsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OtherIncomeandExpenseItemsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expense Items (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expense Items - Schedule of Breakdown of Expenses by Nature (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OtherIntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OtherIntellectualPropertyMember",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Intellectual Property [Member]",
        "label": "Other Intellectual Property Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OtherLossesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OtherLossesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Losses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OtherMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other [Member]",
        "label": "Other Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial liabilities",
        "verboseLabel": "Other financial liabilities, Non- current",
        "label": "Other non-current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r260"
     ]
    },
    "radx_OtherPayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OtherPayablesMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other payables [Member]",
        "label": "Other Payables Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "radx_OtherReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OtherReceivablesMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables [Member]",
        "label": "Other Receivables Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherReserves",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Other reserves",
        "label": "Other reserves"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r319",
      "r324"
     ]
    },
    "ifrs-full_OtherReservesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherReservesMember",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total other reserves [Member]",
        "terseLabel": "Other reserves",
        "label": "Other reserves [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r173",
      "r250"
     ]
    },
    "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax losses and other timing differences for which no deferred tax asset is recognized",
        "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r185"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r344",
      "r355",
      "r365",
      "r398"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r358",
      "r368",
      "r401"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r347",
      "r358",
      "r368",
      "r401"
     ]
    },
    "radx_Over5YearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Over5YearsMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over 5 years [Member]",
        "label": "Over5 Years Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_OwnershipInterestHeldByNoncontrollingInterests": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "OwnershipInterestHeldByNoncontrollingInterests",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership interest held by non-controlling interests",
        "label": "Ownership Interest Held By Noncontrolling Interests",
        "documentation": "Represents the percentage of ownership interest held by non-controlling interests."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PMDAApprovalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PMDAApprovalMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PMDA approval [member]",
        "label": "PMDAApproval Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails",
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of ordinary shares par value",
        "verboseLabel": "New per share",
        "label": "Par value per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r235",
      "r272"
     ]
    },
    "radx_ParentEntityFinancialInformationScheduleofFinancialStatementsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ParentEntityFinancialInformationScheduleofFinancialStatementsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Financial Information - Schedule of Financial Statements (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ParentMember",
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parent [Member]",
        "label": "Parent [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an entity that controls one or more entities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r199"
     ]
    },
    "radx_PatentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PatentCostsMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patent costs [Member]",
        "label": "Patent Costs Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "radx_PaymentForDevelopmentMilestoneToCRT": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentForDevelopmentMilestoneToCRT",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for development milestone (in Euro)",
        "label": "Payment For Development Milestone To CRT",
        "documentation": "Payment for development milestone to CRT."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentForDevelopmentMilestoneToDiaprostAB": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentForDevelopmentMilestoneToDiaprostAB",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for development milestone",
        "label": "Payment For Development Milestone To Diaprost AB",
        "documentation": "Payment for development milestone to diaprost AB."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentForDevelopmentMilestoneToNanoMab": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentForDevelopmentMilestoneToNanoMab",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for development milestone",
        "label": "Payment For Development Milestone To Nano Mab",
        "documentation": "Payment for development milestone to nanomab."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentForDevelopmentMilestoneToPharma15": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentForDevelopmentMilestoneToPharma15",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for development milestone",
        "label": "Payment For Development Milestone To Pharma15",
        "documentation": "Payment for development milestone to Pharma15."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentForDevelopmentMilestoneToRadiopharmVenturesLLC": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentForDevelopmentMilestoneToRadiopharmVenturesLLC",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for development milestone",
        "label": "Payment For Development Milestone To Radiopharm Ventures LLC",
        "documentation": "Payment for development milestone to radiopharm ventures LLC."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentForDevelopmentMilestoneToTRIMT": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentForDevelopmentMilestoneToTRIMT",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for development milestone",
        "label": "Payment For Development Milestone To TRIMT",
        "documentation": "Payment for development milestone to TRIMT."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentOfLicenseAgreementWithCRT": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentOfLicenseAgreementWithCRT",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of license agreement (in Euro)",
        "label": "Payment Of License Agreement With CRT",
        "documentation": "Payment of license agreement with CRT."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentOfLicenseAgreementWithDiaprostAB": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentOfLicenseAgreementWithDiaprostAB",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of license agreement",
        "label": "Payment Of License Agreement With Diaprost AB",
        "documentation": "Payment of license agreement with Diaprost AB."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentOfLicenseAgreementWithNanoMabTechnologyLTD": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentOfLicenseAgreementWithNanoMabTechnologyLTD",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of license agreement",
        "label": "Payment Of License Agreement With Nano Mab Technology LTD",
        "documentation": "Payment of license agreement with nanomab technology limited."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentOfLicenseAgreementWithPharma15": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentOfLicenseAgreementWithPharma15",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of license agreement",
        "label": "Payment Of License Agreement With Pharma15",
        "documentation": "Payment of license agreement with pharma15."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentOfLicenseAgreementWithTRIMT": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentOfLicenseAgreementWithTRIMT",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment of license agreement",
        "label": "Payment Of License Agreement With TRIMT",
        "documentation": "Payment of license agreement with TRIMT."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsForDebtIssueCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsForDebtIssueCosts",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Transaction costs related to loans and borrowings",
        "label": "Payments for debt issue costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for debt issue costs."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "radx_PaymentsForIntellectualProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentsForIntellectualProperty",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Receipts for sale of intellectual property",
        "label": "Payments For Intellectual Property",
        "documentation": "Payments for intellectual property."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentsForLicenseFeeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentsForLicenseFeeLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments for license fee liabilities",
        "label": "Payments For License Fee Liabilities",
        "documentation": "The amount of payments for license fee liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentsForMilestones": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentsForMilestones",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for milestones",
        "label": "Payments For Milestones",
        "documentation": "Payments for milestones."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsForShareIssueCosts",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issue transaction costs",
        "label": "Payments for share issue costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "radx_PaymentsToDirectorRelatedEntities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentsToDirectorRelatedEntities",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to director related entities",
        "label": "Payments To Director Related Entities",
        "documentation": "Payments to director related entities."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PaymentsToDirectorRelatedEntitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PaymentsToDirectorRelatedEntitiesMember",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to director related entities [Member]",
        "label": "Payments To Director Related Entities Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsToSuppliersForGoodsAndServicesAndToAndOnBehalfOfEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsToSuppliersForGoodsAndServicesAndToAndOnBehalfOfEmployees",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments to suppliers and employees (inclusive of GST)",
        "label": "Payments to suppliers for goods and services and to and on behalf of employees"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payments to suppliers for goods and services and to, and on behalf of, employees."
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "radx_PecentageOfFederalTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PecentageOfFederalTaxRate",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal tax rate",
        "label": "Pecentage of Federal Tax Rate",
        "documentation": "Pecentage of federal tax rate."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r391"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r373"
     ]
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfEntitysRevenue",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues percent",
        "label": "Percentage of entity's revenue"
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "radx_PercentageOfNewYorkStateRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PercentageOfNewYorkStateRate",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New york state rate",
        "label": "Percentage of New York State Rate",
        "documentation": "Percentage of new york state rate."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PercentageOfProbabilityOnClinicalTrialSuccess": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PercentageOfProbabilityOnClinicalTrialSuccess",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability on clinical trial success",
        "label": "Percentage Of Probability On Clinical Trial Success",
        "documentation": "It represents percentage of probability on clinical trial success."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PercentageOnProbabilityOnDirectorsAssumption": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PercentageOnProbabilityOnDirectorsAssumption",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability directors\u2019 assumptions",
        "label": "Percentage On Probability On Directors Assumption",
        "documentation": "Percentage on probability of  director's assumptions."
       }
      }
     },
     "auth_ref": []
    },
    "radx_Pharma15AcquisitionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Pharma15AcquisitionMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Pharma15 acquisition [Member]",
        "label": "Pharma15 Acquisition Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Pharma15ContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Pharma15ContingentConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pharma15 Contingent Consideration [Member]",
        "label": "Pharma15 Contingent Consideration Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Pharma15DeferredConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Pharma15DeferredConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pharma15 Deferred Consideration [Member]",
        "label": "Pharma15 Deferred Consideration Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Pharma15Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Pharma15Member",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pharma15 [Member]",
        "label": "Pharma15 Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_PharmaFifteenCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PharmaFifteenCorporationMember",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pharma15 Corporation [Member]",
        "label": "Pharma Fifteen Corporation Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Phase1ClinicalTrialCommencementLimitedToEachOfThe1stIndicationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Phase1ClinicalTrialCommencementLimitedToEachOfThe1stIndicationMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phase 1 clinical trial commencement limited to each of the 1st indication [member]",
        "label": "Phase1 Clinical Trial Commencement Limited To Each Of The1st Indication Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Phase1ClinicalTrialpivotalStudyCommencementLimitedToEachOfThe1stIndicationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Phase1ClinicalTrialpivotalStudyCommencementLimitedToEachOfThe1stIndicationMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phase 1 clinical trial/pivotal study commencement, limited to each of the 1st indication [member]",
        "label": "Phase1 Clinical Trialpivotal Study Commencement Limited To Each Of The1st Indication Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Phase2ClinicalTrialCommencementLimitedToEachOfThe1st3IndicationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Phase2ClinicalTrialCommencementLimitedToEachOfThe1st3IndicationsMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phase 2 clinical trial commencement limited to each of the 1st 3 indications [member]",
        "label": "Phase2 Clinical Trial Commencement Limited To Each Of The1st3 Indications Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Phase2ClinicalTrialpivotalStudyCommencementLimitedToEachOfThe1st3IndicationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Phase2ClinicalTrialpivotalStudyCommencementLimitedToEachOfThe1st3IndicationsMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phase 2 clinical trial/pivotal study commencement, limited to each of the 1st 3 indications [member]",
        "label": "Phase2 Clinical Trialpivotal Study Commencement Limited To Each Of The1st3 Indications Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Phase3ClinicalTrialCommencementLimitedToEachOfThe1st3IndicationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Phase3ClinicalTrialCommencementLimitedToEachOfThe1st3IndicationsMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phase 3 clinical trial commencement limited to each of the 1st 3 indications\t[member]",
        "label": "Phase3 Clinical Trial Commencement Limited To Each Of The1st3 Indications Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Phase3ClinicalTrialpivotalStudyCommencementLimitedToEachOfThe1st3IndicationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Phase3ClinicalTrialpivotalStudyCommencementLimitedToEachOfThe1st3IndicationsMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Phase 3 clinical trial/pivotal study commencement, limited to each of the 1st 3 indications [member]",
        "label": "Phase3 Clinical Trialpivotal Study Commencement Limited To Each Of The1st3 Indications Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_PivalateContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PivalateContingentConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pivalate Contingent Consideration [Member]",
        "label": "Pivalate Contingent Consideration Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_PivalateImperialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PivalateImperialMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pivalate - Imperial [Member]",
        "label": "Pivalate Imperial Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_PivalateIntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PivalateIntellectualPropertyMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pivalate intellectual property [member]",
        "label": "Pivalate Intellectual Property Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_PivalateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PivalateMember",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pivalate [Member]",
        "label": "Pivalate Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_PlanAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PlanAxis",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_PlansNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PlansNameDomain",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plans name [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r375"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid",
        "label": "Portion of consideration paid (received) consisting of cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The portion of consideration paid or received, consisting of cash and cash equivalents, in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Total for all subsidiaries [member]; Cash and cash equivalents; Consideration paid (received)]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "radx_PotentialTaxBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PotentialTaxBenefit",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential tax benefit",
        "label": "Potential Tax Benefit",
        "documentation": "The amount of unused tax losses potential tax benefit."
       }
      }
     },
     "auth_ref": []
    },
    "radx_PotentialTaxBenefitRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "PotentialTaxBenefitRate",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential tax benefit rate",
        "label": "Potential Tax Benefit Rate",
        "documentation": "Percentage of potential tax benefit rate."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Prepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Prepayments",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments",
        "label": "Prepayments"
       }
      },
      "en": {
       "role": {
        "documentation": "Receivables that represent amounts paid for goods and services before they have been delivered."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r323"
     ]
    },
    "ifrs-full_ProbabilityOfDefaultAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProbabilityOfDefaultAxis",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of default [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r309",
      "r317"
     ]
    },
    "ifrs-full_ProbabilityOfDefaultDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProbabilityOfDefaultDomain",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Probability of default [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Probability of default' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r309",
      "r317"
     ]
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from borrowings",
        "label": "Proceeds from borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issues of shares",
        "label": "Proceeds from issuing shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProductsAndServicesAxis",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r299",
      "r313"
     ]
    },
    "ifrs-full_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r299",
      "r313"
     ]
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      },
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/CashFlowInformationScheduleofReconciliationofProfitAfterIncomeTaxtoNetCashInflowFromOperatingActivitiesDetails",
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetails",
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss for the year",
        "totalLabel": "Loss for the year",
        "label": "Profit (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r73",
      "r150",
      "r152",
      "r202",
      "r214",
      "r247",
      "r276",
      "r296",
      "r301"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income tax",
        "terseLabel": "Loss from continuing operations before income tax expense",
        "label": "Profit (loss) before tax"
       }
      }
     },
     "auth_ref": [
      "r128",
      "r311",
      "r312",
      "r320",
      "r321"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Profit (loss) from operating activities"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r452"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r189",
      "r255"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestInJointVenture": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInJointVenture",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership of the joint venture",
        "label": "Proportion of ownership interest in joint venture"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r31",
      "r34",
      "r80"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesDetails",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Owned subsidiary",
        "terseLabel": "Ownership interest held by the group",
        "label": "Proportion of ownership interest in subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r31",
      "r34",
      "r79"
     ]
    },
    "ifrs-full_ProvisionsForEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProvisionsForEmployeeBenefits",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofEmployeeBenefitObligationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Leave obligations",
        "label": "Provisions for employee benefits"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r269"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "radx_RDAdvanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RDAdvanceMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "R&amp;D advance [Member]",
        "label": "RDAdvance Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RDVenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RDVenturesMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "R&amp;D Ventures\t[Member]",
        "label": "RDVentures Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RadiopharmMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RadiopharmMember",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Radiopharm [Member]",
        "label": "Radiopharm Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RadiopharmTheranosticsUSAIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RadiopharmTheranosticsUSAIncMember",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Radiopharm Theranostics (USA) Inc [Member]",
        "label": "Radiopharm Theranostics USAInc Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RadiopharmVenturesLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RadiopharmVenturesLLCMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedBalanceSheetDetails",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofSummarizedStatementofComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Radiopharm Ventures LLC [Member]",
        "label": "Radiopharm Ventures LLCMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r97",
      "r107",
      "r122",
      "r175",
      "r297",
      "r298",
      "r441"
     ]
    },
    "ifrs-full_RangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeDomain",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r97",
      "r107",
      "r122",
      "r175",
      "r297",
      "r298",
      "r441"
     ]
    },
    "ifrs-full_ReceiptsFromSalesOfGoodsAndRenderingOfServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReceiptsFromSalesOfGoodsAndRenderingOfServices",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receipts from customers (inclusive of GST)",
        "label": "Receipts from sales of goods and rendering of services"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of goods and rendering of services."
       }
      }
     },
     "auth_ref": [
      "r291"
     ]
    },
    "ifrs-full_ReceivablesFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReceivablesFromContractsWithCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue from Contract with Customers [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r339",
      "r350",
      "r360",
      "r393"
     ]
    },
    "radx_ReductionInTimeframeForCompletionOfClinicalTrials": {
     "xbrltype": "durationItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ReductionInTimeframeForCompletionOfClinicalTrials",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction in time frame for completion of clinical trials",
        "label": "Reduction In Timeframe For Completion Of Clinical Trials",
        "documentation": "It represents reduction in time frame for completion of clinical trials."
       }
      }
     },
     "auth_ref": []
    },
    "radx_RegulatoryApprovalOfABLAForALicensedProductByTheFDAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RegulatoryApprovalOfABLAForALicensedProductByTheFDAMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulatory Approval of a BLA for a Licensed Product by the FDA\t[member]",
        "label": "Regulatory Approval Of ABLAFor ALicensed Product By The FDAMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RegulatoryApprovalOfABLAorEquivalentInANonUSJurisdictionForALicensedProductByTheChineseEquivalentOfTheFDAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RegulatoryApprovalOfABLAorEquivalentInANonUSJurisdictionForALicensedProductByTheChineseEquivalentOfTheFDAMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulatory Approval of a BLA (or equivalent in a non-US jurisdiction) for a Licensed Product by the Chinese equivalent of the FDA [member]",
        "label": "Regulatory Approval Of ABLAor Equivalent In ANon USJurisdiction For ALicensed Product By The Chinese Equivalent Of The FDAMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RegulatoryApprovalOfABLAorEquivalentInANonUSJurisdictionForALicensedProductByTheEuropeanUnionEquivalentOfTheFDAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RegulatoryApprovalOfABLAorEquivalentInANonUSJurisdictionForALicensedProductByTheEuropeanUnionEquivalentOfTheFDAMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulatory Approval of a BLA (or equivalent in a non-US jurisdiction) for a Licensed Product by the European Union equivalent of the FDA [member]",
        "label": "Regulatory Approval Of ABLAor Equivalent In ANon USJurisdiction For ALicensed Product By The European Union Equivalent Of The FDAMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RegulatoryApprovalOfABLAorEquivalentInANonUSJurisdictionForALicensedProductByTheJapaneseEquivalentOfTheFDAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RegulatoryApprovalOfABLAorEquivalentInANonUSJurisdictionForALicensedProductByTheJapaneseEquivalentOfTheFDAMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulatory Approval of a BLA (or equivalent in a non-US jurisdiction) for a Licensed Product by the Japanese equivalent of the FDA [member]",
        "label": "Regulatory Approval Of ABLAor Equivalent In ANon USJurisdiction For ALicensed Product By The Japanese Equivalent Of The FDAMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonalDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonalDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions - Schedule of Transactions with Key Management Personal (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity2019",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized over a period",
        "label": "Remaining amortisation period of intangible assets material to entity"
       }
      }
     },
     "auth_ref": [
      "r50",
      "r209"
     ]
    },
    "radx_RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remuneration of Auditors - Schedule of Payable for Services by the Auditor (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RepaymentsOfCurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RepaymentsOfCurrentBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of borrowings",
        "label": "Repayments of current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for repayments of current borrowings. [Refer: Current borrowings]"
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and development expenses",
        "terseLabel": "Research and development",
        "label": "Research and development expense"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r210"
     ]
    },
    "radx_ResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ResearchAndDevelopmentMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development [Member]",
        "label": "Research And Development Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ResearchAndDevelopmentPriorYearsRebate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ResearchAndDevelopmentPriorYearsRebate",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development prior year rebate",
        "label": "Research And Development Prior Years Rebate",
        "documentation": "It represents research and development prior year rebate."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ResearchAndDevelopmentTaxIncentiveReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ResearchAndDevelopmentTaxIncentiveReceived",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development tax incentive received",
        "label": "Research And Development Tax Incentive Received",
        "documentation": "Research and development tax incentive received."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ResearchAndDevelopmentsTaxIncentive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ResearchAndDevelopmentsTaxIncentive",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofOtherincomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development tax incentive",
        "label": "Research And Developments Tax Incentive",
        "documentation": "Research and development tax incentive received."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfGainsAndLossesFromInvestmentsInEquityInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfGainsAndLossesFromInvestmentsInEquityInstruments",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Settled Payments",
        "label": "Reserve of gains and losses from investments in equity instruments"
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "ifrs-full_ReserveOfSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfSharebasedPayments",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments",
        "label": "Reserve of share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r340",
      "r351",
      "r361",
      "r394"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r341",
      "r352",
      "r362",
      "r395"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r348",
      "r359",
      "r369",
      "r402"
     ]
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ParentEntityFinancialInformationScheduleofFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r324",
      "r325"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated losses",
        "label": "Retained earnings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r322"
     ]
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofRevenuefromContractwithCustomersDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails",
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofRevenuefromContractwithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "totalLabel": "Total revenue from continuing operations",
        "label": "Revenue"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r128",
      "r148",
      "r151",
      "r155",
      "r156",
      "r158",
      "r280",
      "r296",
      "r320",
      "r321"
     ]
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromContractsWithCustomers",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofRevenuefromContractwithCustomersDetails": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 0.0
      },
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofProfitorLossandOtherComprehensiveIncome",
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetails",
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonMajorCustomersDetails",
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofRevenuefromContractwithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from contracts with customers",
        "verboseLabel": "Contracts with customers",
        "label": "Revenue from contracts with customers"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r99",
      "r162"
     ]
    },
    "radx_RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customers - Schedule of Information on Geographical Regions (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RevenuefromContractwithCustomersScheduleofInformationonMajorCustomersDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RevenuefromContractwithCustomersScheduleofInformationonMajorCustomersDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonMajorCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customers - Schedule of Information on Major Customers (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RightsIssueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RightsIssueMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rights issue [Member]",
        "label": "Rights Issue Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_RightsIssueShortfallMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "RightsIssueShortfallMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rights issue shortfall [Member]",
        "label": "Rights Issue Shortfall Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "radx_ScheduleOfBreakdownOfExpensesByNatureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfBreakdownOfExpensesByNatureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Breakdown Of Expenses By Nature Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfCommercializationPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfCommercializationPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Commercialization Payments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfDevelopmentMilestonePaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfDevelopmentMilestonePaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Development Milestone Payments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfEmployeeOptionPlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfEmployeeOptionPlanAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Employee Option Plan Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfExposureToForeignCurrencyRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfExposureToForeignCurrencyRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Exposure To Foreign Currency Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfExposureToInterestRateRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfExposureToInterestRateRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Exposure To Interest Rate Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfExposureToInterestRateRiskTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfExposureToInterestRateRiskTableTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Exposure to Interest Rate Risk",
        "label": "Schedule Of Exposure To Interest Rate Risk Table Text Block",
        "documentation": "The disclosure of exposure to interest rate risk table text block."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfFinancialLiabilitiesWithSignificantEstimationUncertaintyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfFinancialLiabilitiesWithSignificantEstimationUncertaintyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Liabilities With Significant Estimation Uncertainty Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Statements Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfGroupSSubsidiariesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfGroupSSubsidiariesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Group SSubsidiaries Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfImpactOfForeignCurrencyRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfImpactOfForeignCurrencyRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Impact Of Foreign Currency Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfImpactOfForeignCurrencyRiskTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfImpactOfForeignCurrencyRiskTableTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Impact of Foreign Currency Risk",
        "label": "Schedule Of Impact Of Foreign Currency Risk Table Text Block",
        "documentation": "The disclosure of impact of foreign currency risk table text block."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfImpactOfInterestRateRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfImpactOfInterestRateRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Impact Of Interest Rate Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfImpactOfInterestRateRiskTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfImpactOfInterestRateRiskTableTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Impact of Interest Rate Risk",
        "label": "Schedule Of Impact Of Interest Rate Risk Table Text Block",
        "documentation": "The disclosure of impact of interest rate risk table text block."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfIncomeTaxExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfIncomeTaxExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income Tax Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfInformationOnGeographicalRegionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfInformationOnGeographicalRegionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Information On Geographical Regions Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfInformationOnMajorCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfInformationOnMajorCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Information On Major Customers Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Intangible Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfMaturitiesOfFinancialLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfMaturitiesOfFinancialLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Maturities Of Financial Liabilities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfMaturitiesOfFinancialLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfMaturitiesOfFinancialLiabilitiesTableTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Financial Liabilities",
        "label": "Schedule Of Maturities Of Financial Liabilities Table Text Block",
        "documentation": "The disclosure of maturities of financial liabilities table text block."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfModelInputsForOptionsGrantedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfModelInputsForOptionsGrantedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Model Inputs For Options Granted Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfMovementsInOptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfMovementsInOptionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Movements In Options Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfNumericalReconciliationOfIncomeTaxExpenseToPrimaFacieTaxPayableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfNumericalReconciliationOfIncomeTaxExpenseToPrimaFacieTaxPayableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Numerical Reconciliation Of Income Tax Expense To Prima Facie Tax Payable Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfNumericalReconciliationOfIncomeTaxExpenseToPrimaFacieTaxPayableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfNumericalReconciliationOfIncomeTaxExpenseToPrimaFacieTaxPayableLineItems",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfOtherEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfOtherEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Equity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfOtherFinancialLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfOtherFinancialLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Financial Liabilities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfPayableForServicesByTheAuditorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfPayableForServicesByTheAuditorAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Payable For Services By The Auditor Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfPayableForServicesByTheAuditorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfPayableForServicesByTheAuditorTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Payable for Services by the Auditor",
        "label": "Schedule Of Payable For Services By The Auditor Text Block",
        "documentation": "The disclosure of schedule of payable for services by the auditor."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfShareCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfShareCapitalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfShareOptionsOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfShareOptionsOutstandingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Options Outstanding Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfStatementOfFinancialPositionLineItemOtherReservesAndTheMovementsInTheseReservesDuringTheYearAndPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfStatementOfFinancialPositionLineItemOtherReservesAndTheMovementsInTheseReservesDuringTheYearAndPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Statement Of Financial Position Line Item Other Reserves And The Movements In These Reserves During The Year And Period Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfSummarizedBalanceSheetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfSummarizedBalanceSheetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Summarized Balance Sheet Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfSummarizedBalanceSheetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfSummarizedBalanceSheetTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Summarized Balance Sheet",
        "label": "Schedule Of Summarized Balance Sheet Text Block",
        "documentation": "The disclosure of schedule of summarized balance sheet."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfSummarizedStatementOfComprehensiveLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfSummarizedStatementOfComprehensiveLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Summarized Statement Of Comprehensive Loss Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfSummarizedStatementOfComprehensiveLossTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfSummarizedStatementOfComprehensiveLossTextBlock",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Summarized Statement of Comprehensive Loss",
        "label": "Schedule Of Summarized Statement Of Comprehensive Loss Text Block",
        "documentation": "The disclosure of schedule of summarized statement of comprehensive loss."
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfTaxLossesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfTaxLossesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Tax Losses Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfTradeAndOtherPayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfTradeAndOtherPayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Trade And Other Payables Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfTradeAndOtherPayablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfTradeAndOtherPayablesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Trade and Other Payables [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfTradeAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfTradeAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Trade And Other Receivables Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfTradeAndOtherReceivablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfTradeAndOtherReceivablesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Trade and Other Receivables [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ScheduleOfTransactionsWithKeyManagementPersonalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ScheduleOfTransactionsWithKeyManagementPersonalAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Transactions With Key Management Personal Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "radx_SecondIndicationApprovalAtFirstOfFDAEMAPMDAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "SecondIndicationApprovalAtFirstOfFDAEMAPMDAMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second indication, approval at first of FDA, EMA, PMDA [member]",
        "label": "Second Indication Approval At First Of FDAEMAPMDAMember"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r327"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "radx_ServicesAndDevelopmentPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ServicesAndDevelopmentPeriod",
     "presentation": [
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development period",
        "label": "Services And Development Period",
        "documentation": "It represents services over the expected development period."
       }
      }
     },
     "auth_ref": []
    },
    "radx_SettlementWithLind": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "SettlementWithLind",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Settlement with Lind",
        "label": "Settlement With Lind",
        "documentation": "The amount of settlement with lind."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ShareBasedPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ShareBasedPaymentsMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments [Member]",
        "label": "Share Based Payments Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ShareBasedPaymentsScheduleofEmployeeOptionPlanDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ShareBasedPaymentsScheduleofEmployeeOptionPlanDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments - Schedule of Employee Option Plan (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetailsLineItems",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Model Inputs for Options Granted [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments - Schedule of Model Inputs for Options Granted (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ShareBasedPaymentsScheduleofShareOptionsOutstandingDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ShareBasedPaymentsScheduleofShareOptionsOutstandingDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payments - Schedule of Share Options Outstanding (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareIssueRelatedCost",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Transaction costs",
        "label": "Share issue related cost"
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "ifrs-full_ShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareOptionsMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Options [Member]",
        "label": "Share options [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share options."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "radx_SharePurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "SharePurchasePlanMember",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails",
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Purchase Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_SharesToBeIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "SharesToBeIssued",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares to be issued",
        "label": "Shares To Be Issued",
        "documentation": "Shares to be issued."
       }
      }
     },
     "auth_ref": []
    },
    "radx_SharesToBeIssuedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "SharesToBeIssuedMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares to be issued [Member]",
        "label": "Shares To Be Issued Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesDetails",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r35",
      "r91",
      "r230"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesDomain",
     "presentation": [
      "http://radx.com/20260630/role/InterestsinOtherEntitiesDetails",
      "http://radx.com/20260630/role/InterestsinOtherEntitiesScheduleofGroupsSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r35",
      "r91",
      "r230"
     ]
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Consolidated Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r250"
     ]
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r354",
      "r364",
      "r397"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "auth_ref": []
    },
    "radx_SubsequentEventsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "SubsequentEventsMember",
     "presentation": [
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_SummaryOfMaterialAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "SummaryOfMaterialAccountingPoliciesLineItems",
     "presentation": [
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Material Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_SummaryofMaterialAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "SummaryofMaterialAccountingPoliciesDetailsTable",
     "presentation": [
      "http://radx.com/20260630/role/SummaryofMaterialAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Material Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TRIMTContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TRIMTContingentConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofFinancialLiabilitieswithSignificantEstimationUncertaintyDetails",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TRIMT Contingent Consideration [Member]",
        "label": "TRIMTContingent Consideration Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "ifrs-full_TaxEffectFromChangeInTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxEffectFromChangeInTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "Tax effect from change in tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r185"
     ]
    },
    "radx_TaxEffectOfAccountingExpenditureSubjectToResearchandDevelopmentTaxIncentive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TaxEffectOfAccountingExpenditureSubjectToResearchandDevelopmentTaxIncentive",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_TaxEffectFromChangeInTaxRate",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting expenditure subject to R&amp;D tax incentive",
        "label": "Tax Effect Of Accounting Expenditure Subject To Researchand Development Tax Incentive",
        "documentation": "The amount that represents the difference between the tax expense (income) accounting expenditure subject to R&amp;D tax incentive."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TaxEffectOfAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TaxEffectOfAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax effect of amounts which are not deductible/(taxable) in calculating taxable income:",
        "label": "Tax effect of amounts which are not deductible/(taxable) in calculating taxable income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TaxEffectOfEmployeeLeaveObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TaxEffectOfEmployeeLeaveObligations",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_TaxEffectFromChangeInTaxRate",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee leave obligations",
        "label": "Tax Effect Of Employee Leave Obligations",
        "documentation": "The amount that represents the difference between the tax expense (income) employee leave obligations."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TaxEffectOfPatentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TaxEffectOfPatentCosts",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_TaxEffectFromChangeInTaxRate",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patent costs",
        "label": "Tax Effect Of Patent Costs",
        "documentation": "The amount that represents the difference between the tax expense (income) patent costs."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TaxEffectOfResearchAndDevelopmentTaxIncentive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TaxEffectOfResearchAndDevelopmentTaxIncentive",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_TaxEffectFromChangeInTaxRate",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Research and Development tax incentive",
        "terseLabel": "Other income research and development",
        "label": "Tax Effect Of Research And Development Tax Incentive",
        "documentation": "The amount that represents the difference between the tax expense (income) research and development tax incentive."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TaxEffectOfSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TaxEffectOfSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_TaxEffectFromChangeInTaxRate",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments",
        "label": "Tax Effect Of Sharebased Payments",
        "documentation": "The amount that represents the difference between the tax expense (income) share-based payments."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TaxEffectOfTaxAmortisation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TaxEffectOfTaxAmortisation",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_TaxEffectFromChangeInTaxRate",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization",
        "label": "Tax Effect Of Tax Amortisation",
        "documentation": "The amount of amortisation."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxEffectOfTaxLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxEffectOfTaxLosses",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_TaxEffectFromChangeInTaxRate",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Tax effect of tax losses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r185"
     ]
    },
    "radx_TaxEffectOfUnrealisedCurrencygainslosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TaxEffectOfUnrealisedCurrencygainslosses",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_TaxEffectFromChangeInTaxRate",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized currency (gains)/losses",
        "label": "Tax Effect Of Unrealised Currencygainslosses",
        "documentation": "The amount of unrealised currency (gains)/losses."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TaxEffectOfUnrealizedCurrencyMovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TaxEffectOfUnrealizedCurrencyMovements",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_TaxEffectFromChangeInTaxRate",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized currency movements",
        "label": "Tax Effect Of Unrealized Currency Movements",
        "documentation": "The amount that represents the difference between the tax expense (income) unrealized currency movements."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax rate",
        "label": "Tax expense (income) at applicable tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r185"
     ]
    },
    "radx_TherapeuticDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TherapeuticDevelopmentMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Therapeutic development [member]",
        "label": "Therapeutic Development Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/MaterialEstimatesandJudgementsDetails",
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Top of range [member]",
        "verboseLabel": "Top of Range [Member]",
        "terseLabel": "Top of range [Member]",
        "label": "Top of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r97",
      "r107",
      "r122",
      "r175",
      "r297",
      "r298",
      "r441"
     ]
    },
    "radx_TotalRemunerationForAuditAndOtherAssuranceServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TotalRemunerationForAuditAndOtherAssuranceServicesMember",
     "presentation": [
      "http://radx.com/20260630/role/RemunerationofAuditorsScheduleofPayableforServicesbytheAuditorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total remuneration for audit and other assurance services [Member]",
        "label": "Total Remuneration For Audit And Other Assurance Services Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other payables",
        "verboseLabel": "Trade and other payables, Current",
        "label": "Trade and other current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementsofFinancialPosition",
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade and other receivables Current, Total",
        "terseLabel": "Trade and other receivables",
        "label": "Trade and other current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r257",
      "r268"
     ]
    },
    "ifrs-full_TradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayables",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other payables, Total",
        "label": "Trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]"
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesToTradeSuppliers",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofMaturitiesofFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables",
        "label": "Trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "ifrs-full_TradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other receivables, Total",
        "label": "Trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r241",
      "r257",
      "r268"
     ]
    },
    "radx_TradePayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TradePayablesMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherPayablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables [Member]",
        "label": "Trade Payables Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r323"
     ]
    },
    "ifrs-full_TradeReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeReceivablesMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofTradeandOtherReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables [Member]",
        "label": "Trade receivables [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r134",
      "r138",
      "r226",
      "r228",
      "r306",
      "r446"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://radx.com/20260630/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "radx_Tranche2PlacementSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Tranche2PlacementSharesMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 2 placement shares [Member]",
        "label": "Tranche2 Placement Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_Tranche2PlacementSharesOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "Tranche2PlacementSharesOneMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche 2 placement shares [member]",
        "label": "Tranche2 Placement Shares One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TransactionCostsArisingOnShareIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TransactionCostsArisingOnShareIssues",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs arising on share issues (in Shares)",
        "label": "Transaction Costs Arising On Share Issues",
        "documentation": "Number of shares issued transaction costs arising on share during issued."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TransactionCostsArisingOnShareIssuesValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TransactionCostsArisingOnShareIssuesValue",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs arising on share issues value",
        "label": "Transaction Costs Arising On Share Issues Value",
        "documentation": "Represent the amount of transaction costs arising on share issues value."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TransactionsOccurredWithKeyManagementPersonnel": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TransactionsOccurredWithKeyManagementPersonnel",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsScheduleofTransactionswithKeyManagementPersonnelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transactions occurred with key management personnel",
        "label": "Transactions Occurred With Key Management Personnel",
        "documentation": "The amount of transactions occurred with key management personnel."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TransactionsWithOwnersInTheirCapacityAsOwnersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TransactionsWithOwnersInTheirCapacityAsOwnersAbstract",
     "presentation": [
      "http://radx.com/20260630/role/ConsolidatedStatementofChangesinEquity",
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transactions with owners in their capacity as owners:",
        "verboseLabel": "Transactions with owners in their capacity as owners",
        "label": "Transactions with owners in their capacity as owners [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TransferFromSharebasedPaymentsToEquitySettledPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TransferFromSharebasedPaymentsToEquitySettledPayments",
     "crdr": "credit",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofStatementofFinancialPositionLineItemOtherReservesandtheMovementsinTheseReservesDuringtheYearandPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfer from Share-based payments to equity settled payments",
        "label": "Transfer From Sharebased Payments To Equity Settled Payments",
        "documentation": "Transfer from Share-based payments to equity settled payments."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TransfersUnderLoansFromEntityRelatedPartyTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TransfersUnderLoansFromEntityRelatedPartyTransaction",
     "crdr": "debit",
     "presentation": [
      "http://radx.com/20260630/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans to related parties",
        "label": "Transfers Under Loans From Entity Related Party Transaction",
        "documentation": "Transfers under loans from entity related party transaction."
       }
      }
     },
     "auth_ref": []
    },
    "radx_TravelAndEntertainmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TravelAndEntertainmentMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Travel and entertainment [Member]",
        "label": "Travel And Entertainment Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "radx_TwentyEightZeroEightTwoThousandAndTwentyFoursMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwentyEightZeroEightTwoThousandAndTwentyFoursMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-08-28 [Member]",
        "label": "Twenty Eight Zero Eight Two Thousand And Twenty Fours Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwentyElevenTwoThousandAndTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwentyElevenTwoThousandAndTwentyFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "20/11/2025 [Member]",
        "label": "Twenty Eleven Two Thousand And Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwentyElevenTwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwentyElevenTwoThousandTwentyFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-11-20 [Member]",
        "label": "Twenty Eleven Two Thousand Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwentyFiveElevenTwoThousandTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwentyFiveElevenTwoThousandTwentyFourMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-11-25 [Member]",
        "label": "Twenty Five Eleven Two Thousand Twenty Four Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwentyFiveElevenTwoThousandTwentyFoursMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwentyFiveElevenTwoThousandTwentyFoursMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-11-25 [Member]",
        "label": "Twenty Five Eleven Two Thousand Twenty Fours Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyFourZeroTwoZeroSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyFourZeroTwoZeroSixMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-02-06 [Member]",
        "label": "Two Thousand And Twenty Four Zero Two Zero Six Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyOneTwelveTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyOneTwelveTwentyOneMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021-12-21 [Member]",
        "label": "Two Thousand And Twenty One Twelve Twenty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyOneZeroEightZeroTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyOneZeroEightZeroTwoMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021-08-02 [Member]",
        "label": "Two Thousand And Twenty One Zero Eight Zero Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyOneZeroFourTwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyOneZeroFourTwentySixMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021-04-26 [Member]",
        "label": "Two Thousand And Twenty One Zero Four Twenty Six Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyOneZeroFourZeroFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyOneZeroFourZeroFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021-04-05 [Member]",
        "label": "Two Thousand And Twenty One Zero Four Zero Five Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyOneZeroNineThirteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyOneZeroNineThirteenMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021-09-13 [Member]",
        "label": "Two Thousand And Twenty One Zero Nine Thirteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyOneZeroSevenTwentyEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyOneZeroSevenTwentyEightMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021-07-28 [Member]",
        "label": "Two Thousand And Twenty One Zero Seven Twenty Eight Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyOneZeroSixTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyOneZeroSixTwentySevenMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021-06-27 [Member]",
        "label": "Two Thousand And Twenty One Zero Six Twenty Seven Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyOneZeroThreeTwentyNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyOneZeroThreeTwentyNineMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021-03-29 [Member]",
        "label": "Two Thousand And Twenty One Zero Three Twenty Nine Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandAndTwentyTwoElevenTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandAndTwentyTwoElevenTwentyFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022-11-25 [Member]",
        "label": "Two Thousand And Twenty Two Eleven Twenty Five Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFiveTenTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFiveTenTwentyFourMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-10-24 [Member]",
        "label": "TwoThousandTwentyFiveTenTwentyFourMember [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFiveTwelveZeroFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFiveTwelveZeroFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-12-05 [Member]",
        "label": "TwoThousandTwentyFiveTwelveZeroFiveMember [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFiveTwelveZeroNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFiveTwelveZeroNineMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-12-09 [Member]",
        "label": "TwoThousandTwentyFiveTwelveZeroNineMember [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFiveZeroOneTwentyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFiveZeroOneTwentyMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-01-20 [Member]",
        "label": "Two Thousand Twenty Five Zero One Twenty Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFiveZeroSixTwelveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFiveZeroSixTwelveMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025-06-12 [Member]",
        "label": "Two Thousand Twenty Five Zero Six Twelve Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourTwelveSixteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourTwelveSixteenMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-12-16 [Member]",
        "label": "Two Thousand Twenty Four Twelve Sixteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourTwelveThirteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourTwelveThirteenMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-12-13 [Member]",
        "label": "Two Thousand Twenty Four Twelve Thirteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroEightTwentyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroEightTwentyOneMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-08-21 [Member]",
        "label": "Two Thousand Twenty Four Zero Eight Twenty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroEightTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroEightTwentyThreeMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails",
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-08-23 [Member]",
        "verboseLabel": "2024-08-23 [Member]",
        "label": "Two Thousand Twenty Four Zero Eight Twenty Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroFiveOneSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroFiveOneSixMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-05-16 [Member]",
        "label": "Two Thousand Twenty Four Zero Five One Six Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroFourOneFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroFourOneFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-04-15 [Member]",
        "label": "Two Thousand Twenty Four Zero Four One Five Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroNineOneThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroNineOneThreeMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-09-13 [Member]",
        "label": "Two Thousand Twenty Four Zero Nine One Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroOneThirtyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroOneThirtyOneMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-01-31 [Member]",
        "label": "Two Thousand Twenty Four Zero One Thirty One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroOneZeroFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroOneZeroFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-01-05 [Member]",
        "label": "Two Thousand Twenty Four Zero One Zero Five Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroSevenZeroOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroSevenZeroOneMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails",
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-07-01 [Member]",
        "verboseLabel": "2024-07-01 [Member]",
        "label": "Two Thousand Twenty Four Zero Seven Zero One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroThreeTwelveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroThreeTwelveMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-03-12 [Member]",
        "label": "Two Thousand Twenty Four Zero Three Twelve Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroThreeZeroFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroThreeZeroFourMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-03-04 [Member]",
        "label": "Two Thousand Twenty Four Zero Three Zero Four Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroTwoOneFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroTwoOneFourMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-02-14 [Member]",
        "label": "Two Thousand Twenty Four Zero Two One Four Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyFourZeroTwoZeroNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyFourZeroTwoZeroNineMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-02-09 [Member]",
        "label": "Two Thousand Twenty Four Zero Two Zero Nine Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeElevenFourteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeElevenFourteenMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-11-14 [Member]",
        "label": "Two Thousand Twenty Three Eleven Fourteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeElevenSixteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeElevenSixteenMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-11-16 [Member]",
        "label": "Two Thousand Twenty Three Eleven Sixteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeTwelveMonthFourteenDaysMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeTwelveMonthFourteenDaysMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-12-14 [Member]",
        "label": "Two Thousand Twenty Three Twelve Month Fourteen Days Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeTwelveThirteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeTwelveThirteenMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-12-13 [Member]",
        "label": "Two Thousand Twenty Three Twelve Thirteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeTwelveZeroEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeTwelveZeroEightMember",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesDetails",
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOrdinarySharesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-12-08 [Member]",
        "label": "Two Thousand Twenty Three Twelve Zero Eight Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeZeroFiveEighteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeZeroFiveEighteenMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-05-18 [Member]",
        "label": "Two Thousand Twenty Three Zero Five Eighteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeZeroSevenTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeZeroSevenTwentyFourMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-07-24 [Member]",
        "label": "Two Thousand Twenty Three Zero Seven Twenty Four Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeZeroSevenZeroOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeZeroSevenZeroOneMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-07-01 [Member]",
        "label": "Two Thousand Twenty Three Zero Seven Zero One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeZeroSixZeroOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeZeroSixZeroOneMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-06-01 [Member]",
        "label": "Two Thousand Twenty Three Zero Six Zero One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyThreeZeroTwoZeroSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyThreeZeroTwoZeroSevenMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023-02-07 [Member]",
        "label": "Two Thousand Twenty Three Zero Two Zero Seven Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyTwoElevenSixteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyTwoElevenSixteenMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022-11-16 [Member]",
        "label": "Two Thousand Twenty Two Eleven Sixteen Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyTwoElevenSixteenOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyTwoElevenSixteenOneMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022-11-16 [Member]",
        "label": "Two Thousand Twenty Two Eleven Sixteen One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyTwoZeroFourTwentyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyTwoZeroFourTwentyTwoMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022-04-22 [Member]",
        "label": "Two Thousand Twenty Two Zero Four Twenty Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyTwoZeroSevenZeroOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyTwoZeroSevenZeroOneMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022-07-01 [Member]",
        "label": "Two Thousand Twenty Two Zero Seven Zero One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoThousandTwentyTwoZeroThreeZeroTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoThousandTwentyTwoZeroThreeZeroTwoMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022-03-02 [Member]",
        "label": "Two Thousand Twenty Two Zero Three Zero Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_TwoZeroTwoFourZeroSixZeroOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "TwoZeroTwoFourZeroSixZeroOneMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024-06-01 [Member]",
        "label": "Two Zero Two Four Zero Six Zero One Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfAntidilutiveInstrumentsAxis",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails",
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of antidilutive instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ifrs-full_TypesOfAntidilutiveInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfAntidilutiveInstrumentsDomain",
     "presentation": [
      "http://radx.com/20260630/role/EquityScheduleofMovementsinOptionsDetails",
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of antidilutive instruments [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r108",
      "r109",
      "r110",
      "r112",
      "r129",
      "r132",
      "r133",
      "r193"
     ]
    },
    "ifrs-full_TypesOfRisksDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfRisksDomain",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofExposuretoInterestRateRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r108",
      "r109",
      "r110",
      "r112",
      "r129",
      "r132",
      "r133",
      "r193"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r221"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsDomain",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r221"
     ]
    },
    "radx_UCLAContingentConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UCLAContingentConsiderationMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialAssetsandFinancialLiabilitiesScheduleofOtherFinancialLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "UCLA Contingent Consideration [Member]",
        "label": "UCLAContingent Consideration Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_UCLAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UCLAMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "UCLA [Member]",
        "label": "UCLAMember"
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://radx.com/20260630/role/RevenuefromContractwithCustomersScheduleofInformationonGeographicalRegionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States [Member]",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "radx_USDAUDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "USDAUDMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskDetails",
      "http://radx.com/20260630/role/FinancialRiskManagementScheduleofImpactofForeignCurrencyRiskParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "USD/AUD [Member]",
        "label": "USDAUDMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_USDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "USDMember",
     "presentation": [
      "http://radx.com/20260630/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "USD [Member]",
        "label": "USDMember"
       }
      }
     },
     "auth_ref": []
    },
    "radx_USTaxExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "USTaxExpenseMember",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofNumericalReconciliationofIncomeTaxExpensetoPrimaFacieTaxPayableParentheticalsDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesDetails",
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US tax expense [Member]",
        "label": "USTax Expense Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_UnderlyingOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UnderlyingOrdinaryShares",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying ordinary shares",
        "documentation": "Underlying ordinary shares."
       }
      }
     },
     "auth_ref": []
    },
    "radx_UnderlyingOrdinarySharesPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UnderlyingOrdinarySharesPricePerShare",
     "presentation": [
      "http://radx.com/20260630/role/EventsOccurringAftertheReportingYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying ordinary shares price per share",
        "documentation": "Underlying ordinary shares price per share."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
     "presentation": [
      "http://radx.com/20260630/role/IncomeTaxExpenseScheduleofTaxLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused tax losses for which no deferred tax asset has been recognized",
        "label": "Unused tax losses for which no deferred tax asset recognised"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r187"
     ]
    },
    "radx_UponTheDosingOfTheFinalPatientInAPivotalStudyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UponTheDosingOfTheFinalPatientInAPivotalStudyMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon the dosing of the final patient in a Pivotal Study [member]",
        "label": "Upon The Dosing Of The Final Patient In APivotal Study Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon total worldwide Net Sales of all Licensed Products exceeding [Member]",
        "label": "Upon Total Worldwide Net Sales Of All Licensed Products Exceeding Five Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingFourMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon total worldwide Net Sales of all Licensed Products exceeding [Member]",
        "label": "Upon Total Worldwide Net Sales Of All Licensed Products Exceeding Four Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon total worldwide Net Sales of all Licensed Products exceeding [Member]",
        "label": "Upon Total Worldwide Net Sales Of All Licensed Products Exceeding Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingOneMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon total worldwide Net Sales of all Licensed Products exceeding [Member]",
        "label": "Upon Total Worldwide Net Sales Of All Licensed Products Exceeding One Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingThreeMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsParentheticalsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon total worldwide Net Sales of all Licensed Products exceeding [Member]",
        "label": "Upon Total Worldwide Net Sales Of All Licensed Products Exceeding Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "UponTotalWorldwideNetSalesOfAllLicensedProductsExceedingTwoMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofCommercializationPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Upon total worldwide Net Sales of all Licensed Products exceeding [Member]",
        "label": "Upon Total Worldwide Net Sales Of All Licensed Products Exceeding Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price per share option, Forfeited during the year",
        "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r118",
      "r217"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price per share option, Granted during the year",
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r117",
      "r216"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted average exercise price per share option, Ending balance",
        "periodStartLabel": "Weighted average exercise price per share option, Beginning balance",
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r116",
      "r120",
      "r215",
      "r219"
     ]
    },
    "radx_WeightedAverageExercisePricePerShareOptionVestedAndExercisable": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "WeightedAverageExercisePricePerShareOptionVestedAndExercisable",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofEmployeeOptionPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price per share option, Vested and exercisable",
        "label": "Weighted Average Exercise Price Per Share Option Vested And Exercisable",
        "documentation": "The weighted average exercise price of share options vested exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining contractual life of options outstanding at end of year",
        "label": "Weighted average remaining contractual life of outstanding share options"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price at grant date ($) (in Dollars per share)",
        "label": "Weighted average share price, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://radx.com/20260630/role/LossPerShareScheduleofWeightedAverageNumberofSharesUsedastheDenominatorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of ordinary shares used as the denominator in calculating basic loss per share",
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Number of Shares Used as the Denominator [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "radx_ZeroNineTwelveTwoThousandTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ZeroNineTwelveTwoThousandTwentyFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails",
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofShareOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "09/12/2025 [Member]",
        "terseLabel": "2025-01-30 [Member]",
        "label": "Zero Nine Twelve Two Thousand Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ZeroOneZeroEightTwoThousandAndTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ZeroOneZeroEightTwoThousandAndTwentyFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "01/08/2025 [Member]",
        "label": "Zero One Zero Eight Two Thousand And Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_ZeroOneZeroSevenTwoThousandAndTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "ZeroOneZeroSevenTwoThousandAndTwentyFiveMember",
     "presentation": [
      "http://radx.com/20260630/role/ShareBasedPaymentsScheduleofModelInputsforOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "01/07/2025 [Member]",
        "label": "Zero One Zero Seven Two Thousand And Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "radx_huPSAAntibodyDiaprostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "huPSAAntibodyDiaprostMember",
     "presentation": [
      "http://radx.com/20260630/role/OtherIncomeandExpenseItemsScheduleofBreakdownofExpensesbyNatureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "hu PSA Anti-body (Diaprost) [Member]",
        "label": "hu PSAAntibody Diaprost Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_huPSAAntibodyIntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "huPSAAntibodyIntellectualPropertyMember",
     "presentation": [
      "http://radx.com/20260630/role/ContingentConsiderationDetails",
      "http://radx.com/20260630/role/ContingentConsiderationScheduleofDevelopmentMilestonePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "hu PSA Anti-body intellectual property [member]",
        "label": "hu PSAAntibody Intellectual Property Member"
       }
      }
     },
     "auth_ref": []
    },
    "radx_huPSAAntibodyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://radx.com/20260630",
     "localname": "huPSAAntibodyMember",
     "presentation": [
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesDetails",
      "http://radx.com/20260630/role/NonfinancialAssetsandLiabilitiesScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "hu PSA Anti-body [Member]",
        "label": "hu PSAAntibody Member"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_21_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2025-03-27"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "A19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_A19_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "A20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_A20_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS21_g51-57_TI",
   "URIDate": "2025-03-27"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "18A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2025-03-27"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2025-03-27"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "130",
   "Subparagraph": "f",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_f_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "86",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "88",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_viii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_122_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "76",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "40",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_40_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44H_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "Presentation of a statement of cash flows",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI",
   "URIDate": "2025-03-27"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "29",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_29_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "49",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_49_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "29",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_29&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "1",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_1&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "19B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_a_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI",
   "URIDate": "2025-03-27"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI",
   "URIDate": "2025-03-27"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI",
   "URIDate": "2025-03-27"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2025-03-27"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35K",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2025-03-27"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "Offsetting financial assets and financial liabilities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS07_g13A-13F_TI",
   "URIDate": "2025-03-27"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2026-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "30A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_30A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_108_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_128&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "168",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_168_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "169",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "170",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_170&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "176",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_176&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "178",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "179",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_179_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "186",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_186_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "190",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_190_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "190",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_190&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "192",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "204",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_204&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "218",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "223",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_223_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "224",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_224_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "227",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_227&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "229",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_229&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "230",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "230",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "259",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_259&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "264",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_264_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "266",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "269",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_269&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "271",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_v&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_34_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "43",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "64A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_64A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "71",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "71",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_ii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B12&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B13&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_e&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2026-01-01",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.49",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.49&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "107",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_107&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_51&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_k&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_m&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_q&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "98",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "14",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2025-03-27"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_IG63&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_IG23&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG20C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG20C&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "193",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "71",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r432": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "144",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r433": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r434": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "14",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r435": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r436": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r437": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r438": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r439": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r440": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r441": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r442": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r443": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r444": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_104&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r445": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r446": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r447": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r448": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r449": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r450": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r451": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r452": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard",
   "URIDate": "2025-03-27"
  }
 }
}
